Culp (CULP) 10-Q 7 Mar 25 2025 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Jan. 26, 2025	Mar. 07, 2025
Document and Entity Information [Line Item]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jan. 26, 2025
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2025
Entity Registrant Name	CULP INC
Entity Central Index Key	0000723603
Current Fiscal Year End Date	--04-27
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Trading Symbol	CULP
Entity Common Stock, Shares Outstanding		12,559,129
Entity File Number	1-12597
Entity Tax Identification Number	56-1001967
Entity Address, Address Line One	410 W. English Road 5th Floor
Entity Address, City or Town	High Point
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	27262
City Area Code	336
Local Phone Number	889-5161
Entity Incorporation State Country Code	NC
Title of 12(b) Security	Common Stock, par value $.05/ Share
Security Exchange Name	NYSE
Document Quarterly Report	true
Document Transition Report	false
Former Address [Member]
Document and Entity Information [Line Item]
Entity Address, Address Line One	1823 Eastchester Drive
Entity Address, City or Town	High Point
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	27265-1402

CONSOLIDATED STATEMENTS OF NET

CONSOLIDATED STATEMENTS OF NET LOSS - USD ($)	3 Months Ended				9 Months Ended
	Jan. 26, 2025		Jan. 28, 2024		Jan. 26, 2025		Jan. 28, 2024
Income Statement [Abstract]
Net sales	$ 52,253,000		$ 60,418,000		$ 164,464,000		$ 175,804,000
Cost of sales	(45,906,000)		(52,715,000)		(147,050,000)		(153,067,000)
Gross profit	6,347,000		7,703,000		17,414,000		22,737,000
Selling, general and administrative expenses	(8,579,000)		(9,493,000)		(27,235,000)		(29,366,000)
Restructuring expense	(1,655,000)	[1],[2]	50,000	[1],[2]	(6,317,000)	[3],[4]	(432,000)	[3],[4]
Loss from operations	(3,887,000)		(1,740,000)		(16,138,000)		(7,061,000)
Interest expense	(63,000)				(121,000)
Interest income	255,000		284,000		761,000		911,000
Other expense	15,000		(705,000)		(898,000)		(560,000)
Loss before income taxes	(3,680,000)		(2,161,000)		(16,396,000)		(6,710,000)
Income tax expense	(446,000)		(1,027,000)		(635,000)		(2,244,000)
Net loss	$ (4,126,000)		$ (3,188,000)		$ (17,031,000)		$ (8,954,000)
Net loss per share - basic	$ (0.33)		$ (0.26)		$ (1.36)		$ (0.72)
Net loss per share - diluted	$ (0.33)		$ (0.26)		$ (1.36)		$ (0.72)
Average shares outstanding, basic	12,559,000		12,470,000		12,514,000		12,419,000
Average shares outstanding, diluted	12,559,000		12,470,000		12,514,000		12,419,000
[1] The restructuring credit of $ 50,000 for the three months ended January 28, 2024 , represents a gain on the sale of equipment related to the discontinuation of production of cut and sewn upholstery kits in Ouanaminthe, Haiti. During the three months ended January 26, 2025, restructuring expense of $ 1.7 million mostly relates to the mattress fabrics segment. The $ 1.7 million restructuring expense represents (i) $ 1.5 million for the consolidation of our mattress fabrics operations located in Quebec, Canada into our facility located in Stokesdale, North Carolina and (ii) $ 176,000 for employee termination benefits, partially offset by (iii) a net gain of $( 33,000 ) for the impairment and sale of equipment. See Note 10 to the consolidated financial statements for further details and description of our Fiscal 2025 Restructuring Plan. Restructuring expense of $ 432,000 for the nine months ending January 28, 2024 , represents a $ 329,000 impairment charge associated with equipment and $ 103,000 for employee termination benefits related to the discontinuation of production of cut and sewn upholstery kits in Ouanaminthe, Haiti. During the nine months ending January 26, 2025, restructuring expense of $ 6.3 million mostly relates to the mattress fabrics segment. The $ 6.3 million restructuring expense represents (i) $ 2.7 million for the consolidation of our mattress fabrics operations located in Quebec, Canada into our facility located in Stokesdale, North Carolina, (ii) $ 1.5 million for impairment of and accelerated depreciation related to property, plant, and equipment, (iii) $ 1.4 million for employee termination benefits, and (iv) $ 849,000 for lease termination costs, partially offset by a gain on sale and disposal of equipment totaling $( 174,000 ). See Note 10 to the consolidated financial statements for further details and description of our Fiscal 2025 Restructuring Plan.

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 26, 2025	Jan. 28, 2024	Jan. 26, 2025	Jan. 28, 2024
Consolidated Statements of Comprehensive (Loss) Income
Net loss	$ (4,126)	$ (3,188)	$ (17,031)	$ (8,954)
Unrealized holding (loss) gain on investments, net of tax	(5)	94	98	69
Comprehensive loss	$ (4,131)	$ (3,094)	$ (16,933)	$ (8,885)

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Jan. 26, 2025	Apr. 28, 2024		Jan. 28, 2024
Current assets:
Cash and cash equivalents	$ 5,279,000	$ 10,012,000	[1]	$ 12,585,000
Short-term investments - rabbi trust	1,753,000	903,000	[1]	937,000
Accounts receivable, net	23,159,000	21,138,000	[1]	23,686,000
Inventories	48,599,000	44,843,000	[1]	46,877,000
Short-term notes receivable	526,000	264,000	[1]	260,000
Current income taxes receivable	1,137,000	350,000	[1]	476,000
Assets held for sale	2,214,000
Other current assets	2,619,000	3,371,000	[1]	4,237,000
Total current assets	85,286,000	80,881,000	[1]	89,058,000
Property, plant and equipment, net	25,939,000	33,182,000	[1]	34,021,000
Right of use assets	6,103,000	6,203,000	[1]	6,952,000
Intangible assets	1,594,000	1,876,000	[1]	1,970,000
Long-term investments - rabbi trust	6,250,000	7,102,000	[1]	7,083,000
Long-term notes receivable	1,254,000	1,462,000	[1]	1,530,000
Deferred income taxes	490,000	518,000	[1]	531,000
Other assets	639,000	830,000	[1]	853,000
Total assets	127,555,000	132,054,000	[1]	141,998,000
Current liabilities:
Line of credit	5,384,000
Accounts payable - trade	32,717,000	25,607,000	[1]	29,793,000
Accounts payable - capital expenditures	439,000	343,000	[1]	19,000
Operating lease liability - current	2,025,000	2,061,000	[1]	2,524,000
Deferred compensation - current	1,753,000	903,000	[1]	937,000
Deferred revenue	697,000	1,495,000	[1]	1,798,000
Accrued expenses	6,079,000	6,726,000	[1]	7,300,000
Accrued restructuring	723,000
Income taxes payable - current	828,000	972,000	[1]	1,070,000
Total current liabilities	50,645,000	38,107,000	[1]	43,441,000
Operating lease liability - long-term	3,127,000	2,422,000	[1]	2,656,000
Income taxes payable - long-term	1,400,000	2,088,000	[1]	2,072,000
Deferred income taxes	6,582,000	6,379,000	[1]	6,177,000
Deferred compensation - long-term	6,151,000	6,929,000	[1]	6,856,000
Total liabilities	67,905,000	55,925,000	[1]	61,202,000
Commitments and Contingencies (Notes 11, 17, and 18)
Shareholders' equity
Preferred stock, $0.05 par value, authorized 10,000,000
Common stock, $0.05 par value, authorized 40,000,000 shares, issued and outstanding 12,559,129 at January 26, 2025; 12,469,903 at January 28, 2024, and 12,469,903 at April 28, 2024	628,000	624,000	[1]	624,000
Capital contributed in excess of par value	45,461,000	45,011,000	[1]	44,843,000
Accumulated earnings	13,345,000	30,376,000	[1]	35,241,000
Accumulated other comprehensive income	216,000	118,000	[1]	88,000
Total shareholders' equity	59,650,000	76,129,000	[1]	80,796,000
Total liabilities and shareholders' equity	$ 127,555,000	$ 132,054,000	[1]	$ 141,998,000
[1] Derived from audited consolidated financial statements.

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jan. 26, 2025	Apr. 28, 2024	[1]	Jan. 28, 2024
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.05	$ 0.05		$ 0.05
Preferred stock, authorized shares	10,000,000	10,000,000		10,000,000
Common stock, par value	$ 0.05	$ 0.05		$ 0.05
Common stock, authorized shares	40,000,000	40,000,000		40,000,000
Common stock, issued	12,559,129	12,469,903		12,469,903
Common stock, outstanding	12,559,129	12,469,903		12,469,903
[1] Derived from audited consolidated financial statements.

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Jan. 26, 2025	Jan. 28, 2024
Cash flows from operating activities:
Net loss	$ (17,031)	$ (8,954)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	4,288	4,897
Non-cash inventory credit	(1,022)	(1,978)
Amortization	301	291
Stock-based compensation	522	747
Deferred income taxes	231	172
Gain sale of equipment	(27)	(284)
Non-cash restructuring expenses	2,143	330
Foreign currency exchange loss (gain)	(97)	(347)
Changes in assets and liabilities:
Accounts receivable	(2,029)	1,040
Inventories	(2,730)
Other current assets	737	(1,190)
Other assets	98	(107)
Accounts payable – trade	7,184	963
Deferred revenue	(798)	606
Accrued restructuring	753
Accrued expenses and deferred compensation	(335)	(1,437)
Income taxes	(1,613)	(719)
Net cash used in operating activities	(9,425)	(5,970)
Cash flows from investing activities:
Capital expenditures	(2,440)	(3,249)
Proceeds from the sale of equipment	1,450	363
Proceeds from note receivable	270	240
Proceeds from the sale of investments (rabbi trust)	699	1,224
Purchase of investments (rabbi trust)	(599)	(704)
Net cash used in investing activities	(620)	(2,126)
Cash flows from financing activities:
Procceds from line credit	7,898
Payments on lines of credit	(2,500)
Common stock surrendered for withholding taxes payable	(68)	(146)
Net cash provided by (used in) financing activities	5,330	(146)
Effect of exchange rate changes on cash and cash equivalents	(18)	(137)
Decrease in cash and cash equivalents	(4,733)	(8,379)
Cash and cash equivalents at beginning of period	10,012	20,964
Cash and cash equivalents at end of period	$ 5,279	$ 12,585

CONSOLIDATED STATEMENTS OF SHAR

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands		Total		Common Stock		Capital Contributed in Excess of Par Value		Accumulated Earnings		Accumulated Other Comprehensive Income
Balance at Apr. 30, 2023	[1]	$ 89,080		$ 616		$ 44,250		$ 44,195		$ 19
Balance (in shares) at Apr. 30, 2023	[1]			12,327,414
Net loss		(3,342)						(3,342)
Stock-based compensation		322				322
Unrealized gain on investments		57								57
Immediately vested common stock award				$ 1		(1)
Immediately vested common stock award, (in shares)				16,616
Balance at Jul. 30, 2023		86,117		$ 617		44,571		40,853		76
Balance (in shares) at Jul. 30, 2023				12,344,030
Balance at Apr. 30, 2023	[1]	89,080		$ 616		44,250		44,195		19
Balance (in shares) at Apr. 30, 2023	[1]			12,327,414
Net loss		(8,954)
Balance at Jan. 28, 2024		80,796		$ 624		44,843		35,241		88
Balance (in shares) at Jan. 28, 2024				12,469,903
Balance at Jul. 30, 2023		86,117		$ 617		44,571		40,853		76
Balance (in shares) at Jul. 30, 2023				12,344,030
Net loss		(2,424)						(2,424)
Stock-based compensation		163				163
Unrealized gain on investments		(82)								(82)
Common stock issued in connection with the vesting of time-based restricted stock units				$ 8		(8)
Common stock issued in connection with the vesting of time-based restricted stock units (in shares)				151,653
Common stock surrendered in connection with payroll withholding taxes		(146)		$ (1)		(145)
common stock surrendered in connection with payroll withholding taxes, (in shares)				(25,780)
Balance at Oct. 29, 2023		83,628		$ 624		44,581		38,429		(6)
Balance (in shares) at Oct. 29, 2023				12,469,903
Net loss		(3,188)						(3,188)
Stock-based compensation		262				262
Unrealized gain on investments		94								94
Balance at Jan. 28, 2024		80,796		$ 624		44,843		35,241		88
Balance (in shares) at Jan. 28, 2024				12,469,903
Balance at Apr. 28, 2024		76,129	[2]	$ 624	[3]	45,011	[3]	30,376	[3]	118	[3]
Balance (in shares) at Apr. 28, 2024	[3]			12,469,903
Net loss		(7,261)						(7,261)
Stock-based compensation		176				176
Unrealized gain on investments		80								80
Balance at Jul. 28, 2024		69,124		$ 624		45,187		23,115		198
Balance (in shares) at Jul. 28, 2024				12,469,903
Balance at Apr. 28, 2024		76,129	[2]	$ 624	[3]	45,011	[3]	30,376	[3]	118	[3]
Balance (in shares) at Apr. 28, 2024	[3]			12,469,903
Net loss		(17,031)
Balance at Jan. 26, 2025		59,650		$ 628		45,461		13,345		216
Balance (in shares) at Jan. 26, 2025				12,559,129
Balance at Jul. 28, 2024		69,124		$ 624		45,187		23,115		198
Balance (in shares) at Jul. 28, 2024				12,469,903
Net loss		(5,644)						(5,644)
Stock-based compensation		188				188
Unrealized gain on investments		23								23
Common stock issued in connection with the vesting of time-based restricted stock units				$ 5		(5)
Common stock issued in connection with the vesting of time-based restricted stock units (in shares)				102,720
Common stock surrendered in connection with payroll withholding taxes		(68)		$ (1)		(67)
common stock surrendered in connection with payroll withholding taxes, (in shares)				(13,494)
Balance at Oct. 27, 2024		63,623		$ 628		45,303		17,471		221
Balance (in shares) at Oct. 27, 2024				12,559,129
Net loss		(4,126)						(4,126)
Stock-based compensation		158				158
Unrealized gain on investments		(5)								(5)
Balance at Jan. 26, 2025		$ 59,650		$ 628		$ 45,461		$ 13,345		$ 216
Balance (in shares) at Jan. 26, 2025				12,559,129
[1] Derived from audited consolidated financial statements. Derived from audited consolidated financial statements. Derived from audited consolidated financial statements.

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jan. 26, 2025
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Basis of Presentation

Basis of Presentation	9 Months Ended
	Jan. 26, 2025
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Basis of Presentation	1. Basis of Presentation The accompanying unaudited condensed consolidated financial statements of Culp, Inc. and its majority-owned subsidiaries (the “company”) include all adjustments that are, in the opinion of management, necessary for fair presentation of the results of operations and financial position. All these adjustments are of a normal recurring nature. Results of operations for interim periods may not be indicative of future results. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements that are included in the company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on July 12, 2024, for the fiscal year ended April 28, 2024. The company's nine months ended January 26, 2025, and January 28, 2024, each represent 39-week periods.

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Jan. 26, 2025
Accounting Policies [Abstract]
Significant Accounting Policies	2. Significant Accounting Policies As of January 26, 2025, there were no changes in the nature of our significant accounting policies or the application of those policies from those reported in our Annual Report on Form 10-K for the year then ended April 28, 2024. Recently Adopted Accounting Pronouncements There were no recently adopted accounting pronouncements through the third quarter of fiscal 2025. Recently Issued Accounting Pronouncements In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-07 Improvements to Reportable Segment Disclosures ("ASU 2023-07") which enhances disclosure requirements to segment reporting including (i) significant segment expenses that are regularly provided to the Chief Operating Decision Maker (CODM) that are included within each measure of segment profit or loss, (ii) other segment items by reportable segment as defined by ASU 2023-07, and (iii) the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of each segment's profit or loss in assessing segment performance and deciding how to allocate resources. ASU 2023-07 is effective for public entities starting in annual periods beginning after December 15, 2023, (i.e., our fiscal 2025 annual report) and interim periods beginning after December 15, 2024 (i.e., first quarter of fiscal 2026 interim report). The company expects that the adoption of ASU 2023-07 will not have an impact on our results of operations and financial condition, but will have a material impact on the disclosures required in the notes to the consolidated financial statements, which are disclosed in Note 14. In December 2023, the FASB issued ASU 2023-09 Improvements to Income Tax Disclosures ("ASU 2023-09") , which is an update to Topic 740, Income Taxes. The amendments in this update relate to improvements regarding the transparency of income tax disclosures by requiring consistent categories and greater disaggregation by jurisdiction of information included in the effective income tax rate reconciliation and for income taxes paid. Also, the amendments allow investors to better assess an entity's (i) capital allocation decisions, (ii) worldwide operations, and (iii) related tax risks, tax planning, and operational opportunities that affect the effective income tax rate and prospects for future cash flows. The other amendments in this update improve the effectiveness and comparability of disclosures relating to pretax income (or loss) and income tax expense (or benefit) and remove disclosures that are no longer considered cost beneficial or relevant. ASU 2023-09 is effective for public entities starting in annual periods beginning after December 15, 2024 (i.e., our fiscal 2026 annual report). Early adoption is permitted. The company expects that the adoption of ASU 2023-09 will not have an impact on our results of operations and financial condition, but will have a material impact on the disclosures required in the notes to the consolidated financial statements, which are disclosed in Note 15. In November 2024, the FASB issued ASU 2024 - 03 Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (“ASU 2024-03 ” ) which is an update to Topic 220, Income Statement - Reporting Comprehensive Income. ASU 2024-03 enhances transparency and decision-usefulness of expense disclosures in response to investors' requests for more detailed, disaggregated expense information, enabling a clearer understanding of a public business entity's performance and cost structure. The amendments improve disclosure requirements in financial statement notes for specific expense categories including: (a) purchases of inventory, (b) employee compensation, (c) depreciation, (d) intangible asset amortization, (e) certain amounts that are already required to be disclosed under current generally accepted accounting principles in the same disclosure as other disaggregation requirements, (f) qualitative description of amounts remaining in relevant expense captions that are not necessarily disaggregated quantitatively, as well as (g) the total amount of selling expenses, and in annual reporting periods, the entity's definition of selling expense. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, (i.e., our fiscal 2028 annual report) and interim reporting periods beginning after December 15, 2027 (i.e., first quarter of fiscal 2029 interim report). Early adoption is permitted. The company is currently evaluating ASU 2024-03 to determine the impact it will have on its consolidated financial statements and related disclosures .

Allowance for Doubtful Accounts

Allowance for Doubtful Accounts	9 Months Ended
	Jan. 26, 2025
Receivables [Abstract]
Allowance for Doubtful Accounts	3. Allowance for Doubtful Accounts A summary of the activity in the allowance for doubtful accounts follows: Nine months ended (dollars in thousands) January 26, 2025 January 28, 2024 Beginning balance $ 356 $ 342 Provision for bad debts 150 349 Write-offs, net of recoveries 1 ( 30 ) Ending balance $ 507 $ 661 During the nine-month periods ended January 26, 2025, and January 28, 2024, we assessed the credit risk of our customers within our accounts receivable portfolio. Our risk assessment includes the respective customers’ (i) financial position; (ii) past payment history; (iii) management’s general ability; and (iv) historical loss experience; as well as (v) any other ongoing economic conditions. After our risk assessment was completed, we assigned credit grades to our customers, which, in turn, were used to determine our allowance for doubtful accounts totaling $ 507,000 and $ 661,000 as of January 26, 2025, and January 28, 2024, respectively.

Revenue from Contracts with Cus

Revenue from Contracts with Customers	9 Months Ended
	Jan. 26, 2025
Revenue from Contract with Customer [Abstract]
Revenue from Contracts with Customers	4 . Revenue from Contracts with Customers Nature of Performance Obligations Our operations are classified into two business segments: mattress fabrics and upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers primarily to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics primarily to residential, commercial, and hospitality furniture manufacturers. In addition, the upholstery fabrics segment includes Read Window Products LLC (“Read”), which provides window treatments and sourcing of upholstery fabrics and other products, as well as measuring and installation services for Read’s products, to customers in the hospitality and commercial industries. Read also supplies soft goods such as decorative top sheets, coverlets, duvet covers, bed skirts, bolsters, and pillows. Our primary performance obligations include the sale of mattress fabrics and upholstery fabrics, as well as the performance of customized fabrication and installation services for Read’s products associated with window treatments. Contract Assets & Liabilities Certain contracts, primarily those for customized fabrication and installation services associated with Read, require payments in advance in the form of customer deposits that result in a contract liability which is recorded in the Consolidated Balance Sheets as deferred revenue. If payments in advance are not required, customers may be granted terms which generally range from 15 - 60 days. Our terms are customary within the industries in which we operate and are not considered financing arrangements. There were no contract assets recognized as of January 26, 2025, January 28, 2024, or April 28, 2024. A summary of the activity associated with deferred revenue follows: Nine months ended (dollars in thousands) January 26, 2025 January 28, 2024 Beginning balance $ 1,495 $ 1,192 Revenue recognized on contract liabilities ( 3,134 ) ( 2,893 ) Payments received for services not yet rendered 2,336 3,499 Ending balance $ 697 $ 1,798 Disaggregation of Revenue The following table presents our disaggregated revenue by segment, timing of revenue recognition, and product sales versus services rendered for the three-month period ended January 26, 2025: Mattress Upholstery (dollars in thousands) Fabrics Fabrics Total Products transferred at a point in time $ 28,642 $ 20,345 $ 48,987 Services transferred over time — 3,266 3,266 Total Net Sales $ 28,642 $ 23,611 $ 52,253 The following table presents our disaggregated revenue by segment, timing of revenue recognition, and product sales versus services rendered for the nine-month period ended January 26, 2025: Mattress Upholstery (dollars in thousands) Fabrics Fabrics Total Products transferred at a point in time $ 86,792 $ 68,312 $ 155,104 Services transferred over time — 9,360 9,360 Total Net Sales $ 86,792 $ 77,672 $ 164,464 The following table presents our disaggregated revenue by segment, timing of revenue recognition, and product sales versus services rendered for the three-month period ended January 28, 2024: Mattress Upholstery (dollars in thousands) Fabrics Fabrics Total Products transferred at a point in time $ 30,021 $ 28,604 $ 58,625 Services transferred over time — 1,793 1,793 Total Net Sales $ 30,021 $ 30,397 $ 60,418 The following table presents our disaggregated revenue by segment, timing of revenue recognition, and product sales versus services rendered for the nine-month period ended January 28, 2024: Mattress Upholstery (dollars in thousands) Fabrics Fabrics Total Products transferred at a point in time $ 90,619 $ 77,572 $ 168,191 Services transferred over time — 7,613 7,613 Total Net Sales $ 90,619 $ 85,185 $ 175,804

Inventories

Inventories	9 Months Ended
	Jan. 26, 2025
Inventory Disclosure [Abstract]
Inventories	5. Inventories Inventories are carried at the lower of cost or net realizable value. Cost is determined using the FIFO (first-in, first-out) method. A summary of inventories follows: (dollars in thousands) January 26, January 28, April 28, Raw materials $ 5,502 $ 8,214 $ 6,214 Work-in-process 2,371 2,388 1,854 Finished goods 40,726 36,275 36,775 $ 48,599 $ 46,877 $ 44,843 Measurement of Inventory to Net Realizable Value We recorded a non-cash inventory net credit of $ 1.0 million for the nine months ended January 26, 2025, which represents adjustments made to our inventory markdowns reserve estimated based on our policy for aged inventory for both the mattress and upholstery fabrics segments (see Note 10 of the consolidated financial statements for further details regarding markdowns of inventory associated with the Fiscal 2025 Restructuring Plan ). We recorded a non-cash inventory net credit of $ 2.0 million for the nine months ended January 28, 2024 . This non-cash inventory credit represents a credit of $ 2.0 million related to adjustments made to our inventory markdown reserve estimated based on our policy for aged inventory for both our mattress and upholstery fabrics segments, partially offset by a charge of $ 40,000 which represents markdowns of inventory related to the discontinuance of production of cut and sewn upholstery kits at our facility in Ouanaminthe, Haiti. Assessment As of January 26, 2025, we reviewed our mattress fabrics and upholstery fabrics inventories to determine if any additional reductions of inventory in excess of the amount recorded based on our policy for aged inventory were necessary. Based on our assessment, no additional write downs of inventories to their net realizable value were recorded for the nine months ended January 26, 2025, other than the markdowns of inventory associated with our restructuring activities described in Note 10 of the consolidated financial statements. Based on the current unfavorable macroeconomic conditions related to the home furnishings and bedding industry, it is possible that estimates used by management to determine the write down of inventory to its net realizable value could be materially different from the actual amounts or our results. These differences could result in higher than expected inventory provisions, which could adversely affect the company’s results of operations and financial condition in the near term.

Intangible Assets

Intangible Assets	9 Months Ended
	Jan. 26, 2025
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	6. Intangible Assets A summary of intangible assets follows: (dollars in thousands) January 26, January 28, April 28, Tradename $ 540 $ 540 $ 540 Customer relationships, net 809 1,110 1,035 Non-compete agreement, net 245 320 301 $ 1,594 $ 1,970 $ 1,876 Tradename Our tradename pertains to Read, a separate reporting unit within the upholstery fabrics segment. This tradename was determined to have an indefinite useful life at the time of its acquisition, and therefore is not being amortized. However, we are required to assess this tradename annually or between annual tests if we believe indicators of impairment exist. Based on our assessment as of January 26, 2025, no indicators of impairment existed, and therefore we did no t record any asset impairment charges associated with our tradename through the third quarter of fiscal 2025. Customer Relationships A summary of the change in the carrying amount of our customer relationships follows: Nine months ended (dollars in thousands) January 26, 2025 January 28, 2024 Beginning balance $ 1,035 $ 1,335 Amortization expense ( 226 ) ( 225 ) Ending balance $ 809 $ 1,110 Our customer relationships are amortized on a straight-line basis over useful lives ranging from nine to seventeen years . The gross carrying amount of our customer relationships was $ 3.1 million as of January 26, 2025, January 28, 2024, and April 28, 2024, respectively. Accumulated amortization for these customer relationships was $ 2.3 million, $ 2.0 million, and $ 2.1 million as of January 26, 2025, January 28, 2024, and April 28, 2024, respectively. The remaining amortization expense for each of the next five fiscal years and thereafter are as follows: FY 2025 - $ 75,000 ; FY 2026 - $ 301,000 ; FY 2027 - $ 280,000 ; FY 2028 - $ 51,000 ; FY 2029 - $ 51,000 ; and thereafter - $ 51,000 . The weighted average amortization period for our customer relationships was 3.2 years as of January 26, 2025. Non-Compete Agreement A summary of the change in the carrying amount of our non-compete agreement follows: Nine months ended (dollars in thousands) January 26, 2025 January 28, 2024 Beginning balance $ 301 $ 377 Amortization expense ( 56 ) ( 57 ) Ending balance $ 245 $ 320 Our non-compete agreement is associated with a prior acquisition by our mattress fabrics segment and is amortized on a straight-line basis over the fifteen-year life of the agreement. The gross carrying amount of our non-compete agreement was $ 2.0 million as of January 26, 2025, January 28, 2024, and April 28, 2024, respectively. Accumulated amortization for our non-compete agreement was $ 1.8 million, $ 1.7 million, and $ 1.7 million as of January 26, 2025, January 28, 2024, and April 28, 2024, respectively. The remaining amortization expense for each of the next five years and thereafter are as follows: FY 2025 - $ 19,000 ; FY 2026 - $ 76,000 ; FY 2027 - $ 76,000 ; FY 2028 - $ 74,000 . The weighted average amortization period for the non-compete agreement was 3.3 years as of January 26, 2025. Impairment of Definite Lived Assets - Mattress Fabrics Segment As of January 26, 2025, management reviewed the long-lived assets associated with our mattress fabrics segment, which consisted of property, plant, and equipment, right of use assets, and definite-lived intangible assets (collectively known as the "Mattress Asset Group"), for impairment, as events and changes in circumstances occurred that indicated the carrying amount of the Mattress Asset Group may not be recoverable. The mattress fabrics segment experienced a significant cumulative operating loss totaling $ 35.3 million commencing in the second quarter of fiscal 2023, and continuing through the third quarter of fiscal 2025. We believe this significant cumulative operating loss stemmed from a decline in consumer discretionary spending on mattress products, which we believe was driven by the following factors: (i) inflationary effects of commodities such as gas, food, and other necessities; (ii) a significant increase in interest rates; (iii) the pulling forward of demand for home goods products during the early years of the COVID-19 pandemic, which demand has now shifted to travel, leisure, and other services; and (iv) excess inventory held by customers due to the decline in consumer demand. Based on the above evidence, we were required to determine the recoverability of the Mattress Asset Group, which is classified as held and used, by comparing the carrying amount of the Mattress Asset Group to the sum of the future undiscounted cash flows expected to result from its use and eventual disposition. If the carrying amount of an asset group exceeds its estimated future cash flows, an impairment charge is recognized for the excess of the carrying amount over the fair value of the asset group. The carrying amount of the Mattress Asset Group totaled $ 24.9 million, which represents property, plant, and equipment of $ 24.2 million, right of use assets of $ 200,000 , customer relationships of $ 268,000 , and a non-compete agreement of $ 245,000 . The total carrying amount of the Mattress Asset Group did not exceed the sum of its future undiscounted cash flows from its use and disposition. As a result, we determined there was no impairment associated with the Mattress Asset Group as of January 26, 2025.

Note Receivable

Note Receivable	9 Months Ended
	Jan. 26, 2025
Receivables [Abstract]
Note Receivable	7. Notes Receivable Culp Upholstery Fabrics - Haiti, Ltd. ("CUF Haiti") In connection with the restructuring activity within our upholstery fabrics cut and sew operation located in Ouanaminthe, Haiti, effective January 24, 2023, CUF Haiti entered into an agreement to terminate a lease of a facility (“Termination Agreement”). See Note 10 of the consolidated financial statements for further details regarding this restructuring activity. Pursuant to the terms of the original lease agreement (the “Original Lease”), CUF Haiti was required to pay in advance $ 2.8 million for the full amount of rent due prior to the commencement of the Original Lease, and the initial lease term was set to expire on December 31, 2029 . Pursuant to the terms of the Termination Agreement, the Original Lease was formally terminated when CUF Haiti vacated and returned possession of the leased facility to the lessor. After CUF Haiti vacated and returned possession of the leased facility, a third party (the “Lessee”) took possession of this facility, and the Lessee agreed to pay CUF Haiti $ 2.4 million in the form of a note receivable over a period commencing on April 1, 2023, and ending on December 31, 2029, based on the terms stated in the Termination Agreement. In connection with the Termination Agreement, an affiliate of the Lessee has guaranteed payment in full of all amounts due and payable to CUF Haiti by the Lessee, and CUF Haiti has been fully and unconditionally discharged from all of its remaining obligations under the Original Lease. As of the end of our third quarter of fiscal 2023, the carrying amount of the note receivable totaling $ 2.4 million was recorded at its fair value of $ 2.0 million, which represented the present value of future discounted cash flows based on the payment amounts and timing of such payments due from the Lessee as stated in the Termination Agreement. We used an interest rate of 6 % to determine the present value of the future discounted cash flows, based on significant unobservable inputs and assumptions determined by management such as (i) the credit characteristics of the Lessee and guarantor of the Termination Agreement; (ii) the length of the payment terms as defined in the Termination Agreement; (iii) the payment terms as defined in the Termination Agreement being denominated in USD; and (iv) the fact that the facility is located in, and the Lessee and guarantor conduct business in, Haiti, a foreign country. Since management used significant unobservable inputs and assumptions to determine the fair value of this note receivable, this note receivable was classified as Level 3 within the fair value hierarchy (see Note 12 for further explanation of the fair value hierarchy). Effective May 1, 2023, CUF Haiti formally assigned the $ 2.4 million note receivable to Culp, Inc. (its U.S. parent). The following table represents the remaining future principal payments as of January 26, 2025: (dollars in thousands) 2025 $ 90 2026 360 2027 360 2028 360 2029 360 Thereafter 240 Undiscounted value of note receivable $ 1,770 Less: unearned interest income ( 240 ) Present value of note receivable $ 1,530 As of January 26, 2025, this note receivable totaled $ 1.5 million, of which $ 276,000 and $ 1.3 million were classified as short-term note receivable and long-term note receivable, respectively. As of January 28, 2024, this note receivable totaled $ 1.8 million, of which $ 260,000 an d $ 1.5 million were classified as short-term note receivable and long-term note receivable, respectively. As of April 28, 2024, this note receivable totaled $ 1.7 million, of which $ 264,000 and $ 1.5 million were classified as short-term note receivable and long-term note receivable, respectively. We classified amortization of unearned interest income totaling $ 74,000 and $ 85,000 within interest income on our consolidated statements of net loss during the nine-month periods ended January 26, 2025, and January 28, 2024, respectively. As of January 26, 2025, we believe there is no expected credit loss related to the collectability of this note receivable, as the Lessee has made all of the required principal payments stated in the Termination Agreement. We will continue to evaluate the facts and circumstances at the end of each reporting period to determine if an expected credit loss is deemed necessary. Culp Home Fashions - Haiti, Ltd. ("CHF Haiti") Effective August 2, 2024, CHF Haiti entered into an agreement to terminate a lease of a facility (“CHF Termination Agreement”). Pursuant to the terms of the CHF Termination Agreement, CHF Haiti is entitled to a payment of $ 250,000 from the lessor at the earlier of February 28, 2025, or 15 days after a new lease with a third party lessee is signed. In connection with the CHF Termination Agreement, CHF Haiti has been fully and unconditionally discharged from all of its remaining obligations under this lease. As of January 26, 2025, there is no expected credit loss related to the collectability of this note receivable as it was paid in full on February 28, 2025, (fourth quarter of fiscal 2025) in accordance with the terms of the agreement.

Assets Held for Sale

Assets Held for Sale	9 Months Ended
	Jan. 26, 2025
Discontinued Operations and Disposal Groups [Abstract]
Assets Held for Sale	8. Assets Held for Sale In connection with the closure of our mattress fabrics manufacturing facility located in Quebec, Canada, (see Note 10 of the consolidated financial statements for further details regarding our Fiscal 2025 Restructuring Plan), we had assets held for sale totaling $ 2.2 million that are presented separately on the January 26, 2025, consolidated balance sheet, and are no longer being depreciated. During the third quarter of fiscal 2025, we determined that the carrying value of the assets classified as held for sale were less than or equal to their fair value. The fair value used in this determination was based on quoted market prices and from third party buyer sales offers which are either directly or indirectly observable, and therefore we believe this information is classified as Level 2 within the fair value hierarchy (see Note 12 for further explanation of the fair value hierarchy).

Accrued Expenses

Accrued Expenses	9 Months Ended
	Jan. 26, 2025
Text Block [Abstract]
Accrued Expenses	9. Accrued Expenses A summary of accrued expenses follows: (dollars in thousands) January 26, January 28, April 28, Compensation, commissions and related benefits $ 2,318 $ 3,771 $ 4,204 Other accrued expenses 3,761 3,529 2,522 $ 6,079 $ 7,300 $ 6,726

Restructuring Activities

Restructuring Activities	9 Months Ended
	Jan. 26, 2025
Restructuring and Related Activities [Abstract]
Restructuring Activities	10. Restructuring Activities Mattress Fabrics Segment, Upholstery Fabrics Segment, and Unallocated Corporate Fiscal 2025 Restructuring Plan On April 29, 2024 (first quarter of fiscal 2025), our board of directors made a decision to (1) consolidate the company's North American mattress fabrics operations, including a gradual discontinuation of operations and sale of the company's manufacturing facility located in Quebec, Canada; (2) move a portion of the knitting and finishing capacity from the company's manufacturing facility located in Quebec, Canada to the company's manufacturing facility located in Stokesdale, North Carolina; (3) transition the mattress fabrics segment's weaving operation to a strategic sourcing model through the company's long standing supply partners; (4) consolidate the company's sewn mattress cover operation located in Ouanaminthe, Haiti, from two leased facilities into one building and reduce other operating expenses at this location; as well as (5) reduce unallocated corporate expenses and shared service expenses. As of the end of the third quarter of fiscal 2025, production at our facility located in Quebec, Canada has been discontinued and we have entered into a conditional agreement for the sale of this facility, subject to due diligence and other conditions. The consolidation of our sewn mattress cover operation located in Haiti was completed during the first quarter of fiscal 2025. For fiscal 2025, these actions are expected to result in restructuring and restructuring related charges of approximat ely $ 8.5 million, of which approximately $ 5.3 million is expected to be cash expenditures. The $ 8.5 million of estimated restructuring and restructuring related charges represents approximately $ 8.3 million and $ 155,000 associated with the mattress fabrics and upholstery fabrics segments, respectively. The $ 8.3 million of estimated restructuring and restructuring related charges associated with our mattress fabrics segment represents (i) other associated costs of $ 3.3 million mostly related to relocating equipment from our facility in Quebec, Canada to our facility in Stokesdale, North Carolina, (ii) additional depreciation expense related to the shortening of useful lives of equipment associated with the gradual discontinuance of our operations located in Canada noted above totaling $ 1.3 million, (iii) employee termination benefits of $ 1.4 million, (iv) $ 1.5 million related to losses on disposal and valuation of inventory, and (v) lease termination costs of $ 849,000 , partially offset by net gains on the disposal of equipment totaling $ 42,000 . These restructuring and restructuring related charges exclude any expected gain from the sale of the Canadian facility, which would ultimately reduce the amount of the restructuring charges incurred. Based on changes in business and curre nt unfavorable economic conditions related to the home furnishings and bedding industries, it is possible that the above estimates provided by management, to determine restructuring and restructuring related charges incurred during fiscal 2025 could be materially different from the actual results, and therefore could adversely affect the success of this restructuring plan. The above-referenced conditional agreement for the sale of our Canadian facility includes a purchase price of $ 15.5 million CAD ($ 10.8 million USD as of January 26, 2025), contingent on the satisfaction of certain due diligence and closing conditions. Assuming the completion of the transaction, the company currently expects the proceeds from the sale (net of all taxes and commissions) to exceed the amount of cash restructuring charges incurred in connection with the Fiscal 2025 Restructuring Plan. The following summarizes accrued restructuring costs for the nine-month period ended January 26, 2025: Employee Other Termination Associated (dollars in thousands) Benefits Costs Total Beginning balance $ — $ — $ — Expenses incurred 1,535 2,730 4,265 Change in estimate adjustments ( 107 ) — ( 107 ) Payments ( 896 ) ( 2,509 ) ( 3,405 ) Foreign currency exchange remeasurement ( 14 ) ( 16 ) ( 30 ) Ending Balance $ 518 $ 205 $ 723 The following summarizes restructuring and restructuring related charges for the three-month and nine-month periods ended January 26, 2025: Three Months Ended Nine Months Ended (dollars in thousands) January 26, 2025 January 26, 2025 Additional depreciation expense for shortened useful lives of equipment $ — $ 1,339 Employee termination benefits 176 1,428 Other associated costs 1,512 2,730 Loss on disposal, valuation, and markdowns of inventory 624 1,509 Lease termination costs — 849 Net gain on disposal of equipment ( 33 ) ( 43 ) Restructuring expense and restructuring related charges (1) (2) $ 2,279 $ 7,812 (1) Of the total $ 2.3 million restructuring and restructuring related charges, $ 1.7 million and $ 624,000 were classified within restructuring expense and cost of sales, respectively, in the Consolidated Statement of Net Loss for the three-month period ending January 26, 2025. The $ 2.3 million mostly relates to the mattress fabrics segment. (2) Of the total $ 7.8 million restructuring and restructuring related charges, $ 6.3 million and $ 1.5 million were classified within restructuring expense and cost of sales, respectively, in the Consolidated Statement of Net Loss for the nine-month period ending January 26, 2025. The $ 7.8 million mostly relates to the mattress fabrics segment. Upholstery Fabrics Segment Shanghai, China Upholstery Fabrics Finishing Operation During the fourth quarter of fiscal 2024, we closed our upholstery fabrics finishing in China operation to align with current demand trends and will continue to leverage our strategic supply relationships to meet customer finishing needs. This restructuring activity was completed during the first quarter of fiscal 2025 and resulted in cumulative restructuring and restructuring related charges totaling $ 218,000 . The following summarizes the activity in accrued restructuring costs for the nine-month period ended January 26, 2025: (dollars in thousands) Total Beginning balance (1) $ 3 Expenses incurred (2) 14 Payments ( 17 ) Ending balance $ — (1) Accrued restructuring expense of $ 3,000 was reported within accrued expenses in the Consolidated Balance Sheet for the period ended April 28, 2024. (2) Expenses incurred represent other associated costs and were recognized in our Consolidated Statement of Net Loss for the nine-month period ended January 26, 2025. Ouanaminthe, Haiti Cut and Sew Upholstery Fabrics Operation During the third quarter of fiscal 2023, Culp Upholstery Fabrics - Haiti, Ltd. ("CUF Haiti") entered into an agreement to terminate a lease associated with one facility and, in turn, moved the production of upholstery cut and sewn kits to an existing facility leased by Culp Home Fashions - Haiti, Ltd. ("CHF Haiti") during the fourth quarter of fiscal 2023. Both CUF Haiti and CHF Haiti are indirect wholly-owned subsidiaries of the company. During the first quarter of fiscal 2024, demand for upholstery cut and sewn kits declined more than previously anticipated, resulting in the strategic action to discontinue the production of upholstery cut and sewn kits in Haiti. The following summarizes our restructuring (credit) expense and restructuring related (credit) charge for the three months and nine months ended January 28, 2024: Three Months Ended Nine Months Ended (dollars in thousands) Janaury 28, 2024 Janaury 28, 2024 Employee termination benefits $ — $ 103 Impairment loss - leasehold improvements and equipment — 329 Gains on sale of equipment ( 50 ) — (Gain) loss on disposal and markdowns of inventory ( 61 ) 40 Restructuring expense and restructuring related (credits) charges (1) (2) $ ( 111 ) $ 472 (1) Of the total $( 111,000 ), $( 50,000 ) and $( 61,000 ) were recorded within restructuring credit and cost of sales, respectively, in the Consolidated Statement of Net Loss for the three-month period ended January 28, 2024. (2) Of the total $ 472,000 , $ 432,000 and $ 40,000 were recorded within restructuring expense and cost of sales, respectively, in the Consolidated Statement of Net Loss for the nine-month period ended January 28, 2024 . This restructuring activity was completed during the third quarter of fiscal 2024 and resulted in cumulative restructuring and restructuring related charges of $ 1.3 million.

Lines of Credit

Lines of Credit	9 Months Ended
	Jan. 26, 2025
Debt Disclosure [Abstract]
Lines of Credit	11. Lines of Credit Revolving Credit Agreement – United States Culp, Inc., as borrower (the “borrower”), and Read, as guarantor (the “Guarantor”), are parties to an agreement (the "ABL Credit Agreement") by and among the borrower, the Guarantor and Wells Fargo Bank, National Association, as the lender (the “Lender”), to establish an asset-based revolving credit facility (the “ABL Facility”). The proceeds from the ABL Facility may be used to pay fees and expenses related to the ABL Facility and provide funding for ongoing working capital and general corporate purposes. The ABL Facility may be used for revolving credit loans and letters of credit from time to time up to a maximum principal amount of $ 35.0 million, subject to the limitations described below. The ABL Facility contains a sub-facility that allows the company to issue letters of credit in an aggregate amount not to exceed $ 1.0 million. The amount available under the ABL Facility is limited by a borrowing base consisting of certain eligible accounts receivable and inventory, reduced by specified reserves, as follows: • 85 % of eligible accounts receivable, plus • the least of: o the sum of: ▪ lesser of (i) 65 % of eligible inventory valued at cost based on a first-in first-out basis (net of intercompany profits) and (ii) 85 % of the net-orderly-liquidation value percentage of eligible inventory, plus ▪ the least of (i) 65 % of eligible in-transit inventory valued at cost based on a first-in first-out basis (net of intercompany profits), (ii) 85 % of the net-orderly-liquidation value percentage of eligible in-transit inventory, and (iii) $ 5.0 million, plus ▪ the lesser of (i) 65 % of eligible raw material inventory valued at cost based on a first-in first-out basis (net of intercompany profits) and (ii) 85 % of the net-orderly-liquidation value percentage of eligible raw material inventory In each case, the net-orderly-liquidation value is calculated based on the lower of (i) a first-in first-out basis and (ii) market value, and is (A) net of intercompany profits, (B) net of write-ups and write-downs in value with respect to foreign currency exchange rates and (C) consistent with most recent appraisals received and acceptable to Lender. o $ 22.5 million; and o An amount equal to 200 % of eligible accounts receivable, minus • applicable reserves. The ABL Facility permits both base rate borrowings and borrowings based upon daily simple SOFR (the secured overnight financing rate administered by the Federal Reserve Bank of New York (or its successor)). Borrowings under the ABL Facility bear interest at an annual rate equal to daily simple SOFR plus 150 basis points (if the average monthly excess availability under the ABL Facility is greater than 50%) or 175 basis points (if the average monthly excess availability under the ABL Facility is less than or equal to 50%) or 50 basis points above base rate (if the average monthly excess availability under the ABL Facility is greater than 50%) or 75 basis points above base rate (if the average monthly excess availability under the ABL Facility is less than or equal to 50%), as applicable, with a fee on unutilized commitments at an annual rate of 37.5 basis points and an annual servicing fee of $ 12,000 . The ABL Facility ma tures on January 19, 2026 . The ABL Facility may be prepaid from time to time, in whole or in part, without a prepayment penalty or premium. In addition, customary mandatory prepayments of the loans under the ABL Facility are required upon the occurrence of certain events including, without limitation, outstanding borrowing exposures exceeding the borrowing base and certain dispositions of assets outside of the ordinary course of business. Accrued interest is payable monthly in arrears. The borrower’s obligations under the ABL Facility (and certain related obligations) are guaranteed by the Guarantor. In addition, the ABL Credit Agreement requires that the borrower's future domestic subsidiaries guarantee the ABL Facility on a senior secured basis (such future domestic subsidiaries, together with the Guarantor and the borrower, the "Loan Parties"). The borrower's obligations under the ABL Facility are secured by first priority liens and other security interests on all assets of the Loan Parties, subject to certain exceptions and permitted liens. Cash Dominion . Under the terms of the ABL Facility, if (i) an event of default has occurred or (ii) excess borrowing availability under the ABL Facility (based on the lesser of $ 35.0 million and the borrowing base) (the “Excess Availability”) falls below $ 7.0 million, at such time, the Loan Parties will become subject to cash dominion, which will require prepayment of loans under the ABL Facility with the cash deposited in certain deposit accounts of the Loan Parties, including a concentration account, and will restrict the Loan Parties’ ability to transfer cash from their concentration account. Such cash dominion period (a “Dominion Period”) shall end when Excess Availability shall be equal to or greater than $ 7.0 million for a period of 60 consecutive days and no event of default is continuing. Financial Covenants . The ABL Facility contains a springing covenant requiring that the company’s fixed charge coverage ratio be no less than 1.10 to 1.00 during any period that (i) an event of default has occurred or (ii) Excess Availability under the ABL Facility falls below $ 5.25 million. Such compliance period shall end when Excess Availability shall be equal to or greater than $ 5.25 million for a period of 60 consecutive days and no event of default is continuing. Affirmative and Restrictive Covenants . The ABL Credit Agreement governing the ABL Facility contains customary representations and warranties, affirmative and negative covenants (subject, in each case, to exceptions and qualifications), and events of defaults, including covenants that limit the company’s ability to, among other things: • incur additional indebtedness; • make investments; • pay dividends and make other restricted payments; • sell certain assets; • create liens; • consolidate, merge, sell or otherwise dispose of all or substantially all of the company’s assets; and • enter into transactions with affiliates. Overall Interest is charged at a rate (applicable interest rate of 5.80 %, 6.81 %, and 6.81 % as of January 26, 2025, January 28, 2024, and April 28, 2024, respectively) calculated using the Applicable Margin over SOFR based on the borrower's excess availability under the ABL Facility, as defined in the ABL Credit Agreement. There were $ 925,000 , $ 535,000 , and $ 535,000 of outstanding letters of credit provided by the ABL Credit Agreement as of January 26, 2025, January 28, 2024, and April 28, 2024, respectively. As of January 26, 2025, the borrower had $ 75,000 remaining for the issuance of additional letters of credit under the ABL Credit Agreement. There were no borrowings outstanding under the ABL Credit Agreement as of January 26, 2025, January 28, 2024, and April 28, 2024, respectively. As of January 26, 2025, ou r available borrowings calculated under the provisions of the ABL Credit Agreement totaled $ 23.2 million of which we borrowed $ 6.0 million from January 27, 2025, through March 7, 2025. Denominated in Chinese Yuan Renminbi (“RMB”) Agricultural Bank of China - RMB Unsecured Credit Agreement Effective March 20, 2024, we entered into an unsecured credit agreement denominated in RMB that provides for a line of credit up to 29.0 million RMB ($ 4.0 million USD as of January 26, 2025). Of this 29.0 million RMB line of credit, 9.6 million RMB, 9.7 million RMB, and 9.7 million RMB expire on March 7, 2 025 , March 8, 2025 , and March 9, 2025 , respectively. Interest charged under this agreement is based on the Loan Prime Rate ("LPR") in China minus 50 basis points at the time of borrowing, which represents 2.95 %. As of January 26, 2025, the amount outstanding was 29.0 million RMB ($ 4.0 million USD) which we expect to repay during the fourth quarter when the line of credit expires based on the dates noted in the preceding paragraph. Currently, we are negotiating the terms for a renewal of this agreement, which is expected to be finalized during the fourth quarter of fiscal 2025, and such terms are not expected to adversely affect our liquidity. Bank of China - RMB Credit Agreement Effective November 5, 2024, we entered into a credit agreement (“Agreement”) denominated in RMB that provides 10.0 million RMB ($ 1.4 million USD as of January 26, 2025) for an unsecured working capital loan and 25.0 million RMB ($ 3.5 million USD as of January 26, 2025) for letters of credit, guarantees, and other financing arrangements secured by trade accounts receivable associated with the company’s operations located in China. The working capital loan and letters of credit expire on November 6, 2025 , and July 31, 2025 , respectively. Interest is charged under the Agreement based on the LPR in C hina minus 50 basis points at the time of borrowing which represents 2.60 %. As of January 26, 2025, the amount outstanding under the working capital loan, which represents the total amount available, was 10.0 million RMB ($ 1.4 million USD). The working capital loan was used to fund certain working capital expenditures incurred in China. As of January 26, 2025, there were no outstanding for letters of credit under the Agreement. Overall Our loan agreements require, among other things, that we maintain compliance with certain financial covenants. As of January 26, 2025, we were in compliance with our financial covenants. Interest payments of $ 16,000 were made during the nine-month period ended January 26, 2025. There were no interest payments during the nine-month period ended January 28, 2024.

Fair Value

Fair Value	9 Months Ended
	Jan. 26, 2025
Fair Value Disclosures [Abstract]
Fair Value	12. Fair Value ASC Topic 820 establishes a fair value hierarchy that distinguishes between assumptions based on market data (observable inputs) and the company’s assumptions (unobservable inputs). Determining where an asset or liability falls within that hierarchy depends on the lowest level input that is significant to the fair value measurement as a whole. An adjustment to the pricing method used within either Level 1 or Level 2 inputs could generate a fair value measurement that effectively falls in a lower level in the hierarchy. The hierarchy consists of three broad levels as follows: Level 1 – Quoted market prices in active markets for identical assets or liabilities; Level 2 – Inputs other than Level 1 inputs that are either directly or indirectly observable; and Level 3 – Unobservable inputs developed using the company’s estimates and assumptions, which reflect those that market participants would use. The determination of where an asset or liability falls in the hierarchy requires significant judgment. We evaluate our hierarchy disclosures each quarter based on various factors, and it is possible that an asset or liability may be classified differently from quarter to quarter. However, we expect that changes in classifications between different levels will be rare. Recurring Basis The following tables present information about assets measured at fair value on a recurring basis: Fair value measurements as of January 26, 2025, using: Quoted prices Significant in active other Significant markets for observable unobservable identical assets inputs inputs (amounts in thousands) Level 1 Level 2 Level 3 Total Assets: U.S. Government Money Market Fund $ 6,606 N/A N/A $ 6,606 Growth Allocation Mutual Funds 835 N/A N/A 835 S&P 500 Index Fund 275 N/A N/A 275 Other 287 N/A N/A 287 Fair value measurements as of January 28, 2024, using: Quoted prices Significant in active other Significant markets for observable unobservable identical assets inputs inputs (amounts in thousands) Level 1 Level 2 Level 3 Total Assets: U.S. Government Money Market Fund $ 6,995 N/A N/A $ 6,995 Growth Allocation Mutual Funds 656 N/A N/A 656 S&P 500 Index Fund 156 N/A N/A 156 Other 213 N/A N/A 213 Fair value measurements as of April 28, 2024, using: Quoted prices Significant in active other Significant markets for observable unobservable identical assets inputs inputs (amounts in thousands) Level 1 Level 2 Level 3 Total Assets: U.S. Government Money Market Fund $ 6,910 N/A N/A $ 6,910 Growth Allocation Mutual Funds 691 N/A N/A 691 S&P 500 Index Fund 176 N/A N/A 176 Other 228 N/A N/A 228 Investments - Rabbi Trust We have a rabbi trust (the “Trust”) for the participants in our deferred compensation plan (the “Plan”), that enables participants to direct their contributions to various investment options under the Plan. The investments associated with the Trust consist of a money market fund and various mutual funds that are classified as available-for-sale. As of January 26, 2025, our investments associated with the Trust totaled $ 8.0 million, of wh ich $ 1.8 million, and $ 6.2 million were classified as short-term and long-term, respectively. As of January 28, 2024, our investments associated with the Trust totaled $ 8.0 million, of which $ 937,000 and $ 7.1 million were classified as short-term and long-term, respectively. As of April 28, 2024, our investments associated with the Trust totaled $ 8.0 million, of which $ 903,000 and $ 7.1 million were classified as short-term and long-term, respectively. The investments associated with the Trust had an accumulated unrealized gain (loss) of $ 216,000 , $ 88,000 , and $ 118,000 as of January 26, 2025, January 28, 2024, and April 28, 2024, respectively. The fair value of our long-term investments associated with the Trust approximates their cost basis. Other The carrying amount of our cash and cash equivalents, accounts receivable, other current assets, lines of credit, accounts payable, and accrued expenses approximated their fair value because of the short maturity of these financial instruments.

Net Loss Per Share

Net Loss Per Share	9 Months Ended
	Jan. 26, 2025
Earnings Per Share [Abstract]
Net Loss Per Share	13. Net Loss Per Share Basic net loss per share is computed using the weighted-average number of shares outstanding during the period. Diluted net loss per share uses the weighted-average number of shares outstanding during the period plus the dilutive effect of stock-based compensation calculated using the treasury stock method. Weighted average shares used in the computation of basic and diluted net loss per share were 12,559,000 and 12,470,000 for the three months ended January 26, 2025, and January 28, 2024, respectively. Shares of unvested common stock that were not included in the computation of diluted net loss per share consist of the following: Three Months Ended (in thousands) January 26, 2025 January 28, 2024 Antidilutive effect from decrease in the price per share of our common stock — 15 Antidilutive effect from net loss incurred during the fiscal quarter 123 81 Total unvested shares of common stock not included in computation of diluted net loss per share 123 96 Weighted average shares used in the computation of basic and diluted net loss per share were 12,514,000 and 12,419,000 for the nine months ending January 26, 2025, and January 28, 2024, respectively. Shares of unvested common stock that were not included in the computation of diluted net loss per share consist of the following: Nine months ended (in thousands) January 26, 2025 January 28, 2024 antidilutive effect from decrease in the price per share of our common stock — 4 antidilutive effect from net loss incurred during the fiscal year 135 126 total unvested shares of common stock not included in computation of diluted net loss per share 135 130

Segment Information

Segment Information	9 Months Ended
	Jan. 26, 2025
Segment Reporting [Abstract]
Segment Information	14. Segment Information Overall Our operations are classified into two business segments: mattress fabrics and upholstery fabrics. Mattress Fabrics The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers primarily to bedding manufacturers. Upholstery Fabrics The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to customers in the residential, commercial, and hospitality industries. In addition, this segment includes Read, which provides window treatments and sourcing of upholstery fabrics and other products, as well as measuring and installation services for Read’s products, to customers in the hospitality and commercial industries. Read also supplies soft goods such as decorative top sheets, coverlets, duvet covers, bed skirts, bolsters, and pillows. Financial Information We evaluate the operating performance of our business segments based upon (loss) income from operations before certain unallocated corporate expenses and other items that are not expected to occur on a regular basis. Cost of sales for each segment includes costs to develop, manufacture, or source our products, including costs such as raw material and finished goods purchases, direct and indirect labor, overhead, and incoming freight charges. Unallocated corporate expenses primarily represent compensation and benefits for certain executives and their support staff, all costs associated with being a public company, amortization of intangible assets, and other miscellaneous expenses. Segment assets include assets used in the operations of each segment and consist of accounts receivable, inventories, property, plant, and equipment, and right of use assets. The mattress fabrics segment also includes assets held for sale associated with property, plant, and equipment related to the Fiscal 2025 Restructuring Plan announced on April 29, 2024 (see Note 10 to the consolidated financial statements for further details regarding this restructuring plan). Intangible assets are not included in segment assets, as these assets are not used by the Chief Operating Decision Maker to evaluate the respective segment’s operating performance, allocate resources to individual segments, or determine executive compensation. Statements of operations for our operating segments are as follows: Three months ended January 26, 2025 January 28, 2024 Net sales by segment: Mattress fabrics $ 28,642 $ 30,021 Upholstery fabrics 23,611 30,397 Net sales $ 52,253 $ 60,418 Gross profit: Mattress fabrics $ 2,743 $ 1,520 Upholstery fabrics 4,228 6,122 Segment gross profit 6,971 7,642 Restructuring related (charge) credit (1)(2) ( 624 ) 61 Gross profit $ 6,347 $ 7,703 Selling, general, and administrative expenses by segment: Mattress fabrics $ 3,176 $ 3,102 Upholstery fabrics 3,549 4,030 Unallocated corporate expenses 1,854 2,361 Selling, general, and administrative expenses $ 8,579 $ 9,493 (Loss) income from operations by segment: Mattress fabrics $ ( 433 ) $ ( 1,582 ) Upholstery fabrics 679 2,092 Unallocated corporate expenses ( 1,854 ) ( 2,361 ) Total segment loss from operations $ ( 1,608 ) $ ( 1,851 ) Restructuring related (charge) credit (1) (2) ( 624 ) 61 Restructuring expense (3)(4) ( 1,655 ) 50 Loss from operations $ ( 3,887 ) $ ( 1,740 ) Interest expense ( 63 ) — Interest income 255 284 Other income (expense) 15 ( 705 ) Loss before income taxes $ ( 3,680 ) $ ( 2,161 ) (1) During the three months ended January 26, 2025, gross profit includes restructuring related charges totaling $ 624,000 for losses on the disposal and valuation of inventory related to the gradual discontinuation of operations at our manufacturing facility located in Quebec, Canada. (2) During the three months ended January 28, 2024, gross profit includes a restructuring related credit of $ 61,000 for the gain on disposal of inventory related to the discontinuation of production of cut and sewn upholstery kits at the company's facility located in Ouanaminthe, Haiti. (3) During the three months ended January 26, 2025, restructuring expense of $ 1.7 million mostly relates to the mattress fabrics segment. The $ 1.7 million restructuring expense represents (i) $ 1.5 million for the consolidation of our mattress fabrics operations located in Quebec, Canada into our facility located in Stokesdale, North Carolina and (ii) $ 176,000 for employee termination benefits, partially offset by (iii) a net gain of $( 33,000 ) for the impairment and sale of equipment. See Note 10 to the consolidated financial statements for further details and description of our Fiscal 2025 Restructuring Plan. (4) The restructuring credit of $ 50,000 for the three months ended January 28, 2024 , represents a gain on the sale of equipment related to the discontinuation of production of cut and sewn upholstery kits in Ouanaminthe, Haiti. Nine months ended January 26, 2025 January 28, 2024 Net sales by segment: Mattress fabrics $ 86,792 $ 90,619 Upholstery fabrics 77,672 85,185 Net sales $ 164,464 $ 175,804 Gross profit: Mattress fabrics $ 4,862 $ 5,997 Upholstery fabrics 14,061 16,780 Total segment gross profit $ 18,923 $ 22,777 Restructuring related charge (1) (2) ( 1,509 ) ( 40 ) Gross profit $ 17,414 $ 22,737 Selling, general, and administrative expenses by segment: Mattress fabrics $ 9,880 $ 9,913 Upholstery fabrics 11,056 11,969 Unallocated corporate expenses 6,299 7,484 Selling, general, and administrative expenses $ 27,235 $ 29,366 (Loss) income from operations by segment: Mattress fabrics $ ( 5,018 ) $ ( 3,916 ) Upholstery fabrics 3,005 4,811 Unallocated corporate expenses ( 6,299 ) ( 7,484 ) Total segment loss from operations $ ( 8,312 ) $ ( 6,589 ) Restructuring related charge (1) (2) ( 1,509 ) ( 40 ) Restructuring expense (3) (4) ( 6,317 ) ( 432 ) Loss from operations $ ( 16,138 ) $ ( 7,061 ) Interest expense ( 121 ) — Interest income 761 911 Other expense ( 898 ) ( 560 ) Loss before income taxes $ ( 16,396 ) $ ( 6,710 ) (1 ) During the nine months ended January 26, 2025, gross profit includes restructuring related charges totaling $ 1.5 million for losses on the disposal and valuation of inventory related to the gradual discontinuation of operations at our manufacturing facility located in Quebec, Canada. (2) During the nine months ending January 28, 2024, gross profit includes a restructuring related charge of $ 40,000 , which represents markdowns of inventory related to the discontinuation of production of cut and sewn upholstery kits at the company's facility located in Ouanaminthe, Haiti. 3) During the nine months ending January 26, 2025, restructuring expense of $ 6.3 million mostly relates to the mattress fabrics segment. The $ 6.3 million restructuring expense represents (i) $ 2.7 million for the consolidation of our mattress fabrics operations located in Quebec, Canada into our facility located in Stokesdale, North Carolina, (ii) $ 1.5 million for impairment of and accelerated depreciation related to property, plant, and equipment, (iii) $ 1.4 million for employee termination benefits, and (iv) $ 849,000 for lease termination costs, partially offset by a gain on sale and disposal of equipment totaling $( 174,000 ). See Note 10 to the consolidated financial statements for further details and description of our Fiscal 2025 Restructuring Plan. (4) Restructuring expense of $ 432,000 for the nine months ending January 28, 2024 , represents a $ 329,000 impairment charge associated with equipment and $ 103,000 for employee termination benefits related to the discontinuation of production of cut and sewn upholstery kits in Ouanaminthe, Haiti. Balance sheet information for our operating segments follows: (dollars in thousands) January 26, 2025 January 28, 2024 April 28, 2024 Segment assets: Mattress Fabrics: Accounts receivable $ 11,607 $ 11,463 $ 10,003 Inventory 31,377 27,925 27,671 Property, plant and equipment (1) 24,210 32,263 31,472 Right of use assets (2) 200 1,798 1,627 Assets held for sale (3) 2,214 — — Total mattress fabrics assets 69,608 73,449 70,773 Upholstery Fabrics: Accounts receivable 11,552 12,223 11,135 Inventory 17,222 18,952 17,172 Property, plant and equipment (4) 1,117 1,155 1,125 Right of use assets (5) 2,647 2,345 1,952 Total upholstery fabrics assets 32,538 34,675 31,384 Total segment assets 102,146 108,124 102,157 Non-segment assets: Cash and cash equivalents 5,279 12,585 10,012 Short-term investments - rabbi trust 1,753 937 903 Short-term notes receivable 526 260 264 Current income taxes receivable 1,137 476 350 Other current assets 2,619 4,237 3,371 Long-term notes receivable 1,254 1,530 1,462 Deferred income taxes 490 531 518 Property, plant and equipment (6) 612 603 585 Right of use assets (7) 3,256 2,809 2,624 Intangible assets 1,594 1,970 1,876 Long-term investments - rabbi trust 6,250 7,083 7,102 Other assets 639 853 830 Total assets $ 127,555 $ 141,998 $ 132,054 (1) The $ 24.2 million as of January 26, 2025, represents property, plant, and equipment of $ 23.0 million, $ 973,000 and $ 221,000 located in the U.S., Haiti, and Canada, respectively. The $ 32.3 million as of January 28, 2024 , represents property, plant, and equipment of $ 21.9 million, $ 9.8 million, and $ 600,000 located in the U.S., Canada, and Haiti, respectively. The $ 31.5 million as of April 28, 2024, represents property, plant, and equipment of $ 21.5 million, $ 9.4 million, and $ 555,000 located in the U.S., Canada, and Haiti, respectively. (2) The $ 200,000 as of January 26, 2025, represents a right of use asset in Haiti. The $ 1.8 million as of January 28, 2024 , represents right of use assets of $ 1.2 million and $ 604,000 located in Haiti and Canada, respectively. The $ 1.6 million as of April 28, 2024, represents right of use assets of $ 1.1 million and $ 545,000 located in Haiti and Canada, respectively. (3) The $ 2.2 million as of January 26, 2025, represents assets held for sale located in Canada. (4) The $ 1.1 million as of January 26, 2025, represents property, plant, and equipment of $ 1.0 million and $ 83,000 located in the U.S. and China, respectively. The $ 1.2 million as of January 28, 2024 , represents property, plant, and equipment of $ 1.1 million and $ 134,000 located in the U.S. and China, respectively. The $ 1.1 million as of April 28, 2024, represents property, plant, and equipment of $ 1.0 million and $ 120,000 located in the U.S. and China, respectively. (5) The $ 2.6 million as of January 26, 2025, represents right of use assets of $ 1.9 million and $ 764,000 located in China and the U.S., respectively. The $ 2.3 million as of January 28, 2024 , represents right of use assets of $ 944,000 and $ 1.4 million located in China and the U.S., respectively. The $ 2.0 million as of April 28, 2024, represents right of use assets of $ 1.3 million and $ 709,000 located in the U.S. and China, respectively. (6) The $ 612,000 , $ 603,000 , and $ 585,000 as of January 26, 2025, January 28, 2024, and April 28, 2024, respectively, represents property, plant, and equipment associated with unallocated corporate departments and corporate departments shared by our mattress fabrics and upholstery fabrics segments. Property, plant, and equipment associated with our corporate departments are located in the U.S. (7) The $ 3.3 million, $ 2.8 million, and $ 2.6 million as of January 26, 2025, January 28, 2024, and April 28, 2024, respectively, represent right of use assets located in the U.S. Information about capital expenditures and depreciation expense for our operating segments follows: Nine months ended (dollars in thousands) January 26, 2025 January 28, 2024 Capital expenditures (1): Mattress Fabrics $ 1,469 $ 2,828 Upholstery Fabrics 280 219 Unallocated Corporate 789 167 Total capital expenditures $ 2,538 $ 3,214 Depreciation expense: Mattress Fabrics (2) $ 5,166 $ 4,422 Upholstery Fabrics 464 475 Total depreciation expense $ 5,630 $ 4,897 (1) Capital expenditure amounts are stated on an accrual basis. See Consolidated Statements of Cash Flows for capital expenditure amounts on a cash basis. (2) During the nine-month period ended January 26, 2025, depreciation expense for the mattress fabrics segment included additional depreciation expense related to the shortening of useful lives of equipment associated with the gradual discontinuation of operations at our manufacturing facility located in Quebec, Canada. The amount of additional depreciation expense was $ 1.3 million and was classified as restructuring expense in the Consolidated Statements of Net Loss.

Income Taxes

Income Taxes	9 Months Ended
	Jan. 26, 2025
Income Tax Disclosure [Abstract]
Income Taxes	15. Income Taxes Effective Income Tax Rate We recorded income tax expense of $ 635,000, or ( 3.9 %) of loss before income taxes, for the nine-month period ended January 26, 2025, compared with income tax expense of $ 2.2 million, or ( 33.4 %) of loss before income taxes, for the nine-month period ended January 28, 2024. Our effective income tax rates for the nine-month periods ended January 26, 2025, and January 28, 2024, were based upon the estimated effective income tax rate applicable for the full year after giving effect to any significant items related specifically to interim periods. When calculating the annual estimated effective income tax rates for the nine-month periods ended January 26, 2025, and January 28, 2024, we were subject to loss limitation rules. These loss limitation rules require any taxable loss associated with our U.S. or foreign operations to be excluded from the annual estimated effective income tax rate calculation if it was determined that no income tax benefit could be recognized during the current fiscal year. The effective income tax rate can be affected over the fiscal year by the mix and timing of actual earnings from our U.S. operations and foreign subsidiaries located in China, Canada, Haiti, and Vietnam versus annual projections, as well as changes in foreign currency exchange rates in relation to the U.S. dollar. The following schedule summarizes the principal differences between income tax expense at the U.S. federal income tax rate and the effective income tax rate reflected in the consolidated financial statements for the nine-month periods ended January 26, 2025, and January 28, 2024: January 26, January 28, 2025 2024 U.S. federal income tax rate 21.0 % 21.0 % U.S. valuation allowance ( 26.2 ) ( 42.0 ) Tax effects of local currency foreign exchange gain 0.7 3.8 Uncertain income tax positions 4.3 ( 0.1 ) Withholding taxes associated with foreign jurisdictions ( 1.5 ) ( 8.1 ) Captial expenditure deduction - Quebec Canada ( 1.1 ) — Foreign income tax rate differential ( 0.8 ) ( 5.2 ) Stock-based compensation ( 0.4 ) ( 2.9 ) Other 0.1 0.1 ( 3.9 )% ( 33.4 )% Our consolidated effective income tax rates for the first nine months of fiscal 2025 and 2024 were both adversely affected by the mix of earnings between our U.S. operations and foreign subsidiaries, as our taxable income stems mostly from our operations located in China, which has a higher income tax rate than the U.S. In addition, during the first nine months of fiscal 2025 and the first nine months of 2024, we incurred pre-tax losses associated with our U.S. operations for which an income tax benefit was not recorded due to a full valuation allowance applied against our U.S. net deferred income tax assets. The income tax charge associated with the full valuation allowance applied against our U.S. net deferred income tax assets was higher during the first nine months of fiscal 2025 compared with the first nine months of fiscal 2024, as our $( 16.8 ) million U.S. pre-tax loss incurred during the first nine months of fiscal 2025 was greater than the $( 11.3 ) million U.S. pre-tax loss incurred during the first nine months of fiscal 2024. During the first nine months of fiscal 2025, we incurred a greater consolidated pre-tax loss totaling $( 16.4 ) million, compared with $( 6.7 ) million during the first nine months of fiscal 2024. As a result, the principal differences between income tax expense at the U.S. federal income tax rate and the effective income tax rate reflected in the consolidated financial statements were more pronounced during the first nine months of fiscal 2024, as compared with the first nine months of fiscal 2025. U.S. Valuation Allowance We evaluate the realizability of our U.S. net deferred income tax assets to determine if a valuation allowance is required. We assess whether a valuation allowance should be established based on the consideration of all available evidence using a “more-likely-than-not” standard, with significant weight being given to evidence that can be objectively verified. Since the company operates in multiple jurisdictions, we assess the need for a valuation allowance on a jurisdiction-by-jurisdiction basis, considering the effects of local tax law. As of January 26, 2025, we evaluated the realizability of our U.S. net deferred income tax assets to determine if a full valuation allowance was required. Based on our assessment, we determined we still have a recent history of significant cumulative U.S. pre-tax losses in that we experienced U.S. pre-tax losses during each of the last three fiscal years from 2022 through 2024, and we currently expect significant U.S. pre-tax losses to continue during fiscal 2025. As a result of the significant weight of this negative evidence, we believe it is more likely than not that our U.S. net deferred income tax assets will not be fully realizable, and therefore we provided for a full valuation allowance against our U.S. net deferred income tax assets. Based on our assessments as of January 26, 2025, January 28, 2024, and April 28, 2024, valuation allowances against our net deferred income tax assets pertain to the following: (dollars in thousands) January 26, 2025 January 28, 2024 April 28, 2024 U.S. federal and state net deferred income tax assets $ 23,962 $ 19,162 $ 19,674 U.S. capital loss carryforward 2,330 2,330 2,330 $ 26,292 $ 21,492 $ 22,004 Undistributed Earnings We assess whether the undistributed earnings from our foreign subsidiaries will be reinvested indefinitely or eventually distributed to our U.S. parent company and whether we are required to record a deferred income tax liability for those undistributed earnings from foreign subsidiaries that will not be reinvested indefinitely. As of January 26, 2025, we assessed the liquidity requirements of our U.S. parent company and determined that our undistributed earnings and profits from our foreign subsidiaries would not be reinvested indefinitely and would eventually be distributed to our U.S. parent company. The conclusion reached from this assessment was consistent with prior reporting periods. As a result of the 2017 Tax Cuts and Jobs Act, a U.S. corporation is allowed a 100 % dividend received deduction for earnings and profits received from a 10 % owned foreign corporation. Therefore, a deferred income tax liability will be required only for unremitted withholding taxes associated with earnings and profits generated by our foreign subsidiaries that will ultimately be repatriated to the U.S. parent company. As a result, as of January 26, 2025, January 28, 2024, and April 28, 2024, we recorded a deferred income tax liability of $ 5.1 million, $ 4.7 million, and $ 4.8 million, respectively. Uncertain Income Tax Positions An unrecognized income tax benefit for an uncertain income tax position can be recognized in the first interim period if the more-likely-than-not recognition threshold is met by the end of the reporting period, or is effectively settled through examination, negotiation, or litigation, or the statute of limitations for the relevant taxing authority to examine and challenge the tax position has expired. If it is determined that any of the above conditions occur regarding our uncertain income tax positions, an adjustment to our unrecognized income tax benefit will be recorded at that time. As of January 26, 2025, January 28, 2024, and April 28, 2024, we had a total of $ 1.4 million, $ 1.2 million, and $ 1.3 million of gross unrecognized income tax benefits, of which the entire amount was classified as income taxes payable – long-term in the accompanying Consolidated Balance Sheets. As of January 26, 2025, the unrecognized tax benefit would favorably affect income tax expense in future periods by $ 1.4 million. Our gross unrecognized income tax benefit of $ 1.4 million as of January 26, 2025, relates to income tax positions for which significant change could occur within the next year if the statute of limitations for relevant taxing authorities to examine and challenge the tax position expires. Income Taxes Paid The following table sets forth taxes paid by jurisdiction: Nine Months Nine Months Ended Ended January 26, January 28, (dollars in thousands) 2025 2024 United States Transition Tax Payment 665 499 China Income Taxes, Net of Refunds 1,566 1,803 Canada - Income Taxes, Net of Refunds ( 219 ) 468 $ 2,012 $ 2,770

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Jan. 26, 2025
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	16. Stock-Based Compensation Equity Incentive Plan Description On September 16, 2015, our shareholders approved an equity incentive plan titled the Culp, Inc. 2015 Equity Incentive Plan (the “2015 Plan”). The 2015 Plan authorizes the grant of stock options intended to qualify as incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance-based units, and other equity and cash related awards as determined by the Compensation Committee of our board of directors. An aggregate of 1,200,000 shares of common stock were authorized for issuance under the 2015 Plan, with certain sub-limits that would apply with respect to specific types of awards that may be issued as defined in the 2015 Plan. Effective September 27, 2023, our shareholders approved an amendment and restatement of the 2015 Plan (the "Amended and Restated Plan"). The Amended and Restated Plan authorizes the issuance of an additional 960,000 shares of common stock in addition to the shares of common stock still available for issuance under the 2015 Plan. The Amended and Restated Plan also removed certain sub-limits that previously applied with respect to specific types of awards that may be issued under the 2015 plan. As of January 26, 2025, there were 451,537 shares available for future equity-based grants under the Amended and Restated Plan. Performance-Based Restricted Stock Units We grant performance-based restricted stock units to senior executives which could earn up to a certain number of shares of common stock if certain performance targets are met over a three-fiscal year performance period as defined in the related restricted stock unit award agreements. The number of shares of common stock that are earned based on performance targets that have been achieved may be adjusted based on a market-based total shareholder return component as defined in the related restricted stock unit award agreements. Our performance-based restricted stock units granted to senior executives were measured based on their fair market value on the date of grant. The fair market value per share was determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock for the performance-based component. The following table provides assumptions used to determine the fair market value of the market-based total shareholder return component using the Monte Carlo simulation model on our outstanding performance-based restricted stock units granted to senior executives on August 8, 2024, January 8, 2024, September 28, 2023, and August 10, 2022: August 8, January 8, September 28, August 10, 2024 2024 2023 2022 Closing price of our common stock $ 4.65 $ 5.61 $ 5.59 $ 5.06 Expected volatility of our common stock 35.0 % 33.5 % 37.3 % 48.2 % Expected volatility of peer companies 22.6 - 104.0 % 33.7 - 102.6 % 35.7 - 91.5 % 41.6 - 105.1 % Risk-free interest rate 3.90 % 4.3 % 4.9 % 3.13 % Dividend yield - % - % - % - % Correlation coefficient of peer companies ( 0.01 ) - 0.17 0.01 - 0.21 0.01 - 0.21 0.05 - 0.23 The following table summarizes information related to our grants of performance-based restricted stock units associated with senior executives that were unvested as of January 26, 2025: (2) (3) Performance-Based Restricted Stock Restricted Stock Units Expected Date of Grant Units Awarded to Vest Price Per Share Vesting Period August 8, 2024 (1) 505,003 50,500 $ 5.35 (4) 36 months January 8, 2024 (1) 24,598 4,238 $ 6.23 (5) 31 months September 28, 2023 (1) 192,771 — $ 6.43 (6) 34 months August 10, 2022 (1) 146,048 — $ 5.77 (7) 3 years (1) Performance-based restricted stock units awarded to senior executives. (2) Amounts represent the maximum number of common stock shares that could be earned if certain performance targets are met as defined in the related restricted stock unit agreements. (3) Compensation cost is based on an assessment each reporting period to determine the probability of whether or not certain performance goals will be met and how many shares are expected to be earned as of the end of the vesting period. These amounts represent the number of shares that were expected to vest as of January 26, 2025. (4) Price per share represents the fair market value per share ($ 1.15 per $1, or an increase of $ 0.70 to the closing price of our common stock on the date of grant) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($ 4.65 ) for the performance-based component of the performance-based restricted stock units granted to senior executives on August 8, 2024. (5) Price per share represents the fair market value per share ($ 1.11 per $1, or an increase of $ 0.62 to the closing price of our common stock on the date of grant) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($ 5.61 ) for the performance-based component of the performance-based restricted stock units granted to a senior executive on January 8, 2024. (6) Price per share represents the fair market value per share ($ 1.15 per $1, or an increase of $ 0.84 to the closing price of our common stock on the date of grant) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($ 5.59 ) for the performance-based component of the performance-based restricted stock units granted to senior executives on September 28, 2023. (7) Price per share represents the fair market value per share ($ 1.14 per $1, or an increase of $ 0.71 to the closing price of our common stock on the date of grant) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($ 5.06 ) for the performance-based component of the performance-based restricted stock units granted to senior executives on August 10, 2022. There were no performance-based restricted stock units that vested during the nine-month periods ended January 26, 2025 and January 28, 2024, respectively. We recor ded compensation expense of $ 49,000 and $ 67,000 within selling, general, and administrative expenses associated with our performance-based restricted stock unit awards for the nine-month periods ended January 26, 2025, and January 28, 2024, respectively. Compensation expense is recorded based on an assessment each reporting period to determine the probability of whether or not certain performance targets will be met and how many shares are expected to be earned as of the end of the vesting period. If certain performance goals are not expected to be achieved, compensation expense would not be recorded, and any previously recognized compensation expense would be reversed. As of January 26, 2025, the remaining unrecognized compensation expense related to our performance-based restricted stock units was $ 240,000 , which is expected to be recognized over a weighted average vesting period of 2.4 years. As of January 26, 2025, performance-based restricted stock units that are expected to vest had a fair value of $ 291,000 . Time-Based Restricted Stock Units The following table summarizes information related to our grants of time-based restricted stock unit awards associated with senior executives, key employees, and outside directors that were unvested as of January 26, 2025: Time-Based Restricted Stock (1) Date of Grant Units Awarded Price Per Share Vesting Period January 6, 2025 (3) 21,506 $ 5.69 3 years September 26, 2024 (2) 46,823 $ 5.98 1 year August 8, 2024 (3) 17,900 $ 4.65 36 months January 8, 2024 (3) 14,758 $ 5.61 31 months September 28, 2023 (3) 86,551 $ 5.59 34 months September 6, 2022 (3) 12,557 $ 4.58 3 years August 10, 2022 (3) 62,053 $ 5.06 35 months (1) Price per share represents closing price of our common stock on the date the respective award was granted. (2) Time-based restricted stock units awarded to outside directors. (3) Time-based restricted stock units awarded to senior executives and key employees. During the nine-month period ended January 26, 2025, time-based restricted stock units totaling 103,320 vested at a fair value of $ 581,000 , or $ 5.63 per share. During the nine-month period ended January 28, 2024, time-based restricted stock units totaling 151,653 , vested at a fair value of $ 857,000 , or $ 5.65 per share. We recor ded compensation expense of $ 473,000 and $ 597,000 within selling, general, and administrative expenses associated with our time-based restricted stock unit awards for the nine-month periods ended January 26, 2025, and January 28, 2024, respectively. As of January 26, 2025, the remaining unrecognized compensation expense related to our time-based restricted stock units was $ 731,000 , which is expected to be recognized over a weighted average vesting period of 1.5 years. As of January 26, 2025, the time-based restricted stock units that are expected to vest had a fair value totaling $ 1.4 million. Immediately Vested Common Stock Awards We granted a total of 16,616 shares of common stock to our outside directors on July 3, 2023. These shares of common stock vested immediately and were measured at their fair value on the date of the grant. The fair value of these awards was $ 5.04 per share on July 3, 2023, which represents the closing price of our common stock on the date of grant. We recorded $ 84,000 of compensation expense within selling, general, and administrative expenses for common stock awards that immediately vested to our outside directors during the nine-month period ended January 28, 2024.

Leases

Leases	9 Months Ended
	Jan. 26, 2025
Assets and Liabilities, Lessee [Abstract]
Leases	17. Leases Overview We lease manufacturing facilities, showroom and office space, distribution centers, and equipment under operating lease arrangements. Our operating leases have remaining lease terms of one to seven years , with renewal options for additional periods ranging up to twelve years . Balance Sheet The right of use assets and lease liabilities associated with our operating leases as of January 26, 2025, January 28, 2024, and April 28, 2024, are as follows: (dollars in thousands) January 26, January 28, April 28, Right of use assets $ 6,103 $ 6,952 $ 6,203 Operating lease liability - current 2,025 2,524 2,061 Operating lease liability – noncurrent 3,127 2,656 2,422 Supplemental Cash Flow Information Nine Months Nine Months (dollars in thousands) January 26, 2025 January 28, 2024 Operating lease liability payments $ 1,694 $ 1,992 Right of use assets exchanged for lease liabilities 2,660 978 Operating lease expense for the three-month periods ended January 26, 2025, and January 28, 2024, was $ 683,000 and $ 789,000 , respectively. Operating lease expense for the nine-month periods ended January 26, 2025, and January 28, 2024, was $ 2.1 million and $ 2.3 million, respectively. Short-term lease and variable lease expenses were immaterial for the three-month and nine-month periods ended January 26, 2025, and January 28, 2024. Other Information Maturity of our operating lease liabilities for the remainder of fiscal 2025, the subsequent next four fiscal years, and thereafter follows: (dollars in thousands) 2025 655 2026 2,217 2027 1,556 2028 388 2029 227 Thereafter 576 $ 5,619 Less: interest ( 467 ) Present value of lease liabilities $ 5,152 As of January 26, 2025, the weighted average remaining lease term and discount rate for our operating leases follows: January 26, 2025 Weighted average lease term (in years) 3.24 Weighted average discount rate 5.50 %

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Jan. 26, 2025
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	18. Commitments and Contingencies Litigation The company is involved from time to time in legal proceedings and claims which arise in the ordinary course of business. Management has determined that it is not reasonably possible that any pending actions, when ultimately concluded and settled, will have a material adverse effect upon the consolidated financial position, consolidated results of operations, or consolidated cash flows of the company. Accounts Payable – Capital Expenditures As of January 26, 2025, January 28, 2024, and April 28, 2024, we had amounts due regarding capital expenditures totaling $ 439,000 , $ 19,000 , and $ 343,000 , respectively, which pertained to outstanding vendor invoices, none of which were financed. Purchase Commitments – Capital Expenditures As of January 26, 2025, we had open purchase commitments to acquire equipment for our mattress fabrics segment totaling $ 600,000 .

Statutory Reserves

Statutory Reserves	9 Months Ended
	Jan. 26, 2025
Text Block [Abstract]
Statutory Reserves	19. Statutory Reserves Our subsidiary located in China was required to transfer 10 % of its net income, as determined in accordance with the People’s Republic of China (PRC) accounting rules and regulations, to a statutory surplus reserve fund until such reserve balance reached 50 % of the company’s registered capital. As of January 26, 2025, the statutory surplus reserve fund represents the 50 % registered capital requirement, and therefore, our subsidiary located in China is no longer required to transfer 10 % of its net income in accordance with PRC accounting rules and regulations. The transfer to this reserve must be made before distributions of any dividend to shareholders. As of January 26, 2025, the company’s statutory surplus reserve was $ 4.0 million. The statutory surplus reserve fund is non-distributable other than during liquidation and can be used to fund previous years’ losses, if any. The statutory surplus reserve fund may be utilized for business expansion or converted into share capital by issuing new shares to existing shareholders in proportion to their shareholding or by increasing the par value of the shares currently held by them provided that the remaining reserve balance after such issue is not less than 25 % of the registered capital. The company’s subsidiary located in China can transfer funds to the parent company, except for the statutory surplus reserve of $ 4.0 million, to assist with debt repayment, capital expenditures, and other expenses of the company’s business.

Common Stock Repurchase Program

Common Stock Repurchase Program	9 Months Ended
	Jan. 26, 2025
Text Block [Abstract]
Common Stock Repurchase Program	20. Common Stock Repurchase Program In March 2020, our board of directors approved an authorization for us to acquire up to $ 5.0 million of our common stock. Under the common stock repurchase program, shares may be purchased from time to time in open market transactions, block trades, through plans established under the Securities Exchange Act Rule 10b5-1, or otherwise. The number of shares purchased and the timing of such purchases are based on working capital requirements, market and general business conditions, and other factors, including alternative investment opportunities. We did no t repurchase any shares of common stock during the nine-month periods ended January 26, 2025, and January 28, 2024, respectively. As of January 26 , 2025, $ 3.2 m illion is available for additional repurchases of our common stock.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	9 Months Ended
	Jan. 26, 2025
Accounting Policies [Abstract]
Recently Adopted and Issued Accounting Pronouncements	Recently Adopted Accounting Pronouncements There were no recently adopted accounting pronouncements through the third quarter of fiscal 2025. Recently Issued Accounting Pronouncements In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-07 Improvements to Reportable Segment Disclosures ("ASU 2023-07") which enhances disclosure requirements to segment reporting including (i) significant segment expenses that are regularly provided to the Chief Operating Decision Maker (CODM) that are included within each measure of segment profit or loss, (ii) other segment items by reportable segment as defined by ASU 2023-07, and (iii) the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of each segment's profit or loss in assessing segment performance and deciding how to allocate resources. ASU 2023-07 is effective for public entities starting in annual periods beginning after December 15, 2023, (i.e., our fiscal 2025 annual report) and interim periods beginning after December 15, 2024 (i.e., first quarter of fiscal 2026 interim report). The company expects that the adoption of ASU 2023-07 will not have an impact on our results of operations and financial condition, but will have a material impact on the disclosures required in the notes to the consolidated financial statements, which are disclosed in Note 14. In December 2023, the FASB issued ASU 2023-09 Improvements to Income Tax Disclosures ("ASU 2023-09") , which is an update to Topic 740, Income Taxes. The amendments in this update relate to improvements regarding the transparency of income tax disclosures by requiring consistent categories and greater disaggregation by jurisdiction of information included in the effective income tax rate reconciliation and for income taxes paid. Also, the amendments allow investors to better assess an entity's (i) capital allocation decisions, (ii) worldwide operations, and (iii) related tax risks, tax planning, and operational opportunities that affect the effective income tax rate and prospects for future cash flows. The other amendments in this update improve the effectiveness and comparability of disclosures relating to pretax income (or loss) and income tax expense (or benefit) and remove disclosures that are no longer considered cost beneficial or relevant. ASU 2023-09 is effective for public entities starting in annual periods beginning after December 15, 2024 (i.e., our fiscal 2026 annual report). Early adoption is permitted. The company expects that the adoption of ASU 2023-09 will not have an impact on our results of operations and financial condition, but will have a material impact on the disclosures required in the notes to the consolidated financial statements, which are disclosed in Note 15. In November 2024, the FASB issued ASU 2024 - 03 Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (“ASU 2024-03 ” ) which is an update to Topic 220, Income Statement - Reporting Comprehensive Income. ASU 2024-03 enhances transparency and decision-usefulness of expense disclosures in response to investors' requests for more detailed, disaggregated expense information, enabling a clearer understanding of a public business entity's performance and cost structure. The amendments improve disclosure requirements in financial statement notes for specific expense categories including: (a) purchases of inventory, (b) employee compensation, (c) depreciation, (d) intangible asset amortization, (e) certain amounts that are already required to be disclosed under current generally accepted accounting principles in the same disclosure as other disaggregation requirements, (f) qualitative description of amounts remaining in relevant expense captions that are not necessarily disaggregated quantitatively, as well as (g) the total amount of selling expenses, and in annual reporting periods, the entity's definition of selling expense. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, (i.e., our fiscal 2028 annual report) and interim reporting periods beginning after December 15, 2027 (i.e., first quarter of fiscal 2029 interim report). Early adoption is permitted. The company is currently evaluating ASU 2024-03 to determine the impact it will have on its consolidated financial statements and related disclosures .

Allowance for Doubtful Accoun_2

Allowance for Doubtful Accounts (Tables)	9 Months Ended
	Jan. 26, 2025
Receivables [Abstract]
Summary of the Activity in the Allowance for Doubtful Accounts	A summary of the activity in the allowance for doubtful accounts follows: Nine months ended (dollars in thousands) January 26, 2025 January 28, 2024 Beginning balance $ 356 $ 342 Provision for bad debts 150 349 Write-offs, net of recoveries 1 ( 30 ) Ending balance $ 507 $ 661

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	9 Months Ended
	Jan. 26, 2025
Revenue from Contract with Customer [Abstract]
Summary of Activity Associated with Deferred Revenue	A summary of the activity associated with deferred revenue follows: Nine months ended (dollars in thousands) January 26, 2025 January 28, 2024 Beginning balance $ 1,495 $ 1,192 Revenue recognized on contract liabilities ( 3,134 ) ( 2,893 ) Payments received for services not yet rendered 2,336 3,499 Ending balance $ 697 $ 1,798
Summary of Disaggregation of Revenue	The following table presents our disaggregated revenue by segment, timing of revenue recognition, and product sales versus services rendered for the three-month period ended January 26, 2025: Mattress Upholstery (dollars in thousands) Fabrics Fabrics Total Products transferred at a point in time $ 28,642 $ 20,345 $ 48,987 Services transferred over time — 3,266 3,266 Total Net Sales $ 28,642 $ 23,611 $ 52,253 The following table presents our disaggregated revenue by segment, timing of revenue recognition, and product sales versus services rendered for the nine-month period ended January 26, 2025: Mattress Upholstery (dollars in thousands) Fabrics Fabrics Total Products transferred at a point in time $ 86,792 $ 68,312 $ 155,104 Services transferred over time — 9,360 9,360 Total Net Sales $ 86,792 $ 77,672 $ 164,464 The following table presents our disaggregated revenue by segment, timing of revenue recognition, and product sales versus services rendered for the three-month period ended January 28, 2024: Mattress Upholstery (dollars in thousands) Fabrics Fabrics Total Products transferred at a point in time $ 30,021 $ 28,604 $ 58,625 Services transferred over time — 1,793 1,793 Total Net Sales $ 30,021 $ 30,397 $ 60,418 The following table presents our disaggregated revenue by segment, timing of revenue recognition, and product sales versus services rendered for the nine-month period ended January 28, 2024: Mattress Upholstery (dollars in thousands) Fabrics Fabrics Total Products transferred at a point in time $ 90,619 $ 77,572 $ 168,191 Services transferred over time — 7,613 7,613 Total Net Sales $ 90,619 $ 85,185 $ 175,804

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Jan. 26, 2025
Inventory Disclosure [Abstract]
Summary of Inventories	A summary of inventories follows: (dollars in thousands) January 26, January 28, April 28, Raw materials $ 5,502 $ 8,214 $ 6,214 Work-in-process 2,371 2,388 1,854 Finished goods 40,726 36,275 36,775 $ 48,599 $ 46,877 $ 44,843

Intangible Assets (Tables)

Intangible Assets (Tables)	9 Months Ended
	Jan. 26, 2025
Summary of Intangible Assets	A summary of intangible assets follows: (dollars in thousands) January 26, January 28, April 28, Tradename $ 540 $ 540 $ 540 Customer relationships, net 809 1,110 1,035 Non-compete agreement, net 245 320 301 $ 1,594 $ 1,970 $ 1,876
Customer Relationships [Member]
Summary of Change in Carrying Amount of Finite-Lived Intangible Assets	A summary of the change in the carrying amount of our customer relationships follows: Nine months ended (dollars in thousands) January 26, 2025 January 28, 2024 Beginning balance $ 1,035 $ 1,335 Amortization expense ( 226 ) ( 225 ) Ending balance $ 809 $ 1,110
Non-Compete Agreement [Member]
Summary of Change in Carrying Amount of Finite-Lived Intangible Assets	A summary of the change in the carrying amount of our non-compete agreement follows: Nine months ended (dollars in thousands) January 26, 2025 January 28, 2024 Beginning balance $ 301 $ 377 Amortization expense ( 56 ) ( 57 ) Ending balance $ 245 $ 320

Note Receivable (Tables)

Note Receivable (Tables)	9 Months Ended
	Jan. 26, 2025
Receivables [Abstract]
Summary of Remaining Future Principal Payments	The following table represents the remaining future principal payments as of January 26, 2025: (dollars in thousands) 2025 $ 90 2026 360 2027 360 2028 360 2029 360 Thereafter 240 Undiscounted value of note receivable $ 1,770 Less: unearned interest income ( 240 ) Present value of note receivable $ 1,530

Accrued Expenses (Tables)

Accrued Expenses (Tables)	9 Months Ended
	Jan. 26, 2025
Text Block [Abstract]
Summary of Accrued Expenses	A summary of accrued expenses follows: (dollars in thousands) January 26, January 28, April 28, Compensation, commissions and related benefits $ 2,318 $ 3,771 $ 4,204 Other accrued expenses 3,761 3,529 2,522 $ 6,079 $ 7,300 $ 6,726

Restructuring Activities (Table

Restructuring Activities (Tables)	9 Months Ended
	Jan. 26, 2025
Restructuring and Related Activities [Abstract]
Summary of Restructuring Expense and Restructuring Related Charges (Credits)	The following summarizes restructuring and restructuring related charges for the three-month and nine-month periods ended January 26, 2025: Three Months Ended Nine Months Ended (dollars in thousands) January 26, 2025 January 26, 2025 Additional depreciation expense for shortened useful lives of equipment $ — $ 1,339 Employee termination benefits 176 1,428 Other associated costs 1,512 2,730 Loss on disposal, valuation, and markdowns of inventory 624 1,509 Lease termination costs — 849 Net gain on disposal of equipment ( 33 ) ( 43 ) Restructuring expense and restructuring related charges (1) (2) $ 2,279 $ 7,812 (1) Of the total $ 2.3 million restructuring and restructuring related charges, $ 1.7 million and $ 624,000 were classified within restructuring expense and cost of sales, respectively, in the Consolidated Statement of Net Loss for the three-month period ending January 26, 2025. The $ 2.3 million mostly relates to the mattress fabrics segment. (2) Of the total $ 7.8 million restructuring and restructuring related charges, $ 6.3 million and $ 1.5 million were classified within restructuring expense and cost of sales, respectively, in the Consolidated Statement of Net Loss for the nine-month period ending January 26, 2025. The $ 7.8 million mostly relates to the mattress fabrics segment. The following summarizes our restructuring (credit) expense and restructuring related (credit) charge for the three months and nine months ended January 28, 2024: Three Months Ended Nine Months Ended (dollars in thousands) Janaury 28, 2024 Janaury 28, 2024 Employee termination benefits $ — $ 103 Impairment loss - leasehold improvements and equipment — 329 Gains on sale of equipment ( 50 ) — (Gain) loss on disposal and markdowns of inventory ( 61 ) 40 Restructuring expense and restructuring related (credits) charges (1) (2) $ ( 111 ) $ 472 (1) Of the total $( 111,000 ), $( 50,000 ) and $( 61,000 ) were recorded within restructuring credit and cost of sales, respectively, in the Consolidated Statement of Net Loss for the three-month period ended January 28, 2024. (2) Of the total $ 472,000 , $ 432,000 and $ 40,000 were recorded within restructuring expense and cost of sales, respectively, in the Consolidated Statement of Net Loss for the nine-month period ended January 28, 2024 .
Summary of Activity in Accrued Restructuring	The following summarizes accrued restructuring costs for the nine-month period ended January 26, 2025: Employee Other Termination Associated (dollars in thousands) Benefits Costs Total Beginning balance $ — $ — $ — Expenses incurred 1,535 2,730 4,265 Change in estimate adjustments ( 107 ) — ( 107 ) Payments ( 896 ) ( 2,509 ) ( 3,405 ) Foreign currency exchange remeasurement ( 14 ) ( 16 ) ( 30 ) Ending Balance $ 518 $ 205 $ 723 The following summarizes the activity in accrued restructuring costs for the nine-month period ended January 26, 2025: (dollars in thousands) Total Beginning balance (1) $ 3 Expenses incurred (2) 14 Payments ( 17 ) Ending balance $ — (1) Accrued restructuring expense of $ 3,000 was reported within accrued expenses in the Consolidated Balance Sheet for the period ended April 28, 2024. (2) Expenses incurred represent other associated costs and were recognized in our Consolidated Statement of Net Loss for the nine-month period ended January 26, 2025.

Fair Value (Tables)

Fair Value (Tables)	9 Months Ended
	Jan. 26, 2025
Fair Value Disclosures [Abstract]
Schedule of Assets Measured at Fair Value on a Recurring Basis	The following tables present information about assets measured at fair value on a recurring basis: Fair value measurements as of January 26, 2025, using: Quoted prices Significant in active other Significant markets for observable unobservable identical assets inputs inputs (amounts in thousands) Level 1 Level 2 Level 3 Total Assets: U.S. Government Money Market Fund $ 6,606 N/A N/A $ 6,606 Growth Allocation Mutual Funds 835 N/A N/A 835 S&P 500 Index Fund 275 N/A N/A 275 Other 287 N/A N/A 287 Fair value measurements as of January 28, 2024, using: Quoted prices Significant in active other Significant markets for observable unobservable identical assets inputs inputs (amounts in thousands) Level 1 Level 2 Level 3 Total Assets: U.S. Government Money Market Fund $ 6,995 N/A N/A $ 6,995 Growth Allocation Mutual Funds 656 N/A N/A 656 S&P 500 Index Fund 156 N/A N/A 156 Other 213 N/A N/A 213 Fair value measurements as of April 28, 2024, using: Quoted prices Significant in active other Significant markets for observable unobservable identical assets inputs inputs (amounts in thousands) Level 1 Level 2 Level 3 Total Assets: U.S. Government Money Market Fund $ 6,910 N/A N/A $ 6,910 Growth Allocation Mutual Funds 691 N/A N/A 691 S&P 500 Index Fund 176 N/A N/A 176 Other 228 N/A N/A 228

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	9 Months Ended
	Jan. 26, 2025
Earnings Per Share [Abstract]
Schedule of Unvested Common Stock not Included in the Computation of Diluted Net Loss Per Share	Shares of unvested common stock that were not included in the computation of diluted net loss per share consist of the following: Three Months Ended (in thousands) January 26, 2025 January 28, 2024 Antidilutive effect from decrease in the price per share of our common stock — 15 Antidilutive effect from net loss incurred during the fiscal quarter 123 81 Total unvested shares of common stock not included in computation of diluted net loss per share 123 96 Shares of unvested common stock that were not included in the computation of diluted net loss per share consist of the following: Nine months ended (in thousands) January 26, 2025 January 28, 2024 antidilutive effect from decrease in the price per share of our common stock — 4 antidilutive effect from net loss incurred during the fiscal year 135 126 total unvested shares of common stock not included in computation of diluted net loss per share 135 130

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Jan. 26, 2025
Segment Reporting [Abstract]
Schedule of Operating Segments Information	Statements of operations for our operating segments are as follows: Three months ended January 26, 2025 January 28, 2024 Net sales by segment: Mattress fabrics $ 28,642 $ 30,021 Upholstery fabrics 23,611 30,397 Net sales $ 52,253 $ 60,418 Gross profit: Mattress fabrics $ 2,743 $ 1,520 Upholstery fabrics 4,228 6,122 Segment gross profit 6,971 7,642 Restructuring related (charge) credit (1)(2) ( 624 ) 61 Gross profit $ 6,347 $ 7,703 Selling, general, and administrative expenses by segment: Mattress fabrics $ 3,176 $ 3,102 Upholstery fabrics 3,549 4,030 Unallocated corporate expenses 1,854 2,361 Selling, general, and administrative expenses $ 8,579 $ 9,493 (Loss) income from operations by segment: Mattress fabrics $ ( 433 ) $ ( 1,582 ) Upholstery fabrics 679 2,092 Unallocated corporate expenses ( 1,854 ) ( 2,361 ) Total segment loss from operations $ ( 1,608 ) $ ( 1,851 ) Restructuring related (charge) credit (1) (2) ( 624 ) 61 Restructuring expense (3)(4) ( 1,655 ) 50 Loss from operations $ ( 3,887 ) $ ( 1,740 ) Interest expense ( 63 ) — Interest income 255 284 Other income (expense) 15 ( 705 ) Loss before income taxes $ ( 3,680 ) $ ( 2,161 ) (1) During the three months ended January 26, 2025, gross profit includes restructuring related charges totaling $ 624,000 for losses on the disposal and valuation of inventory related to the gradual discontinuation of operations at our manufacturing facility located in Quebec, Canada. (2) During the three months ended January 28, 2024, gross profit includes a restructuring related credit of $ 61,000 for the gain on disposal of inventory related to the discontinuation of production of cut and sewn upholstery kits at the company's facility located in Ouanaminthe, Haiti. (3) During the three months ended January 26, 2025, restructuring expense of $ 1.7 million mostly relates to the mattress fabrics segment. The $ 1.7 million restructuring expense represents (i) $ 1.5 million for the consolidation of our mattress fabrics operations located in Quebec, Canada into our facility located in Stokesdale, North Carolina and (ii) $ 176,000 for employee termination benefits, partially offset by (iii) a net gain of $( 33,000 ) for the impairment and sale of equipment. See Note 10 to the consolidated financial statements for further details and description of our Fiscal 2025 Restructuring Plan. (4) The restructuring credit of $ 50,000 for the three months ended January 28, 2024 , represents a gain on the sale of equipment related to the discontinuation of production of cut and sewn upholstery kits in Ouanaminthe, Haiti. Nine months ended January 26, 2025 January 28, 2024 Net sales by segment: Mattress fabrics $ 86,792 $ 90,619 Upholstery fabrics 77,672 85,185 Net sales $ 164,464 $ 175,804 Gross profit: Mattress fabrics $ 4,862 $ 5,997 Upholstery fabrics 14,061 16,780 Total segment gross profit $ 18,923 $ 22,777 Restructuring related charge (1) (2) ( 1,509 ) ( 40 ) Gross profit $ 17,414 $ 22,737 Selling, general, and administrative expenses by segment: Mattress fabrics $ 9,880 $ 9,913 Upholstery fabrics 11,056 11,969 Unallocated corporate expenses 6,299 7,484 Selling, general, and administrative expenses $ 27,235 $ 29,366 (Loss) income from operations by segment: Mattress fabrics $ ( 5,018 ) $ ( 3,916 ) Upholstery fabrics 3,005 4,811 Unallocated corporate expenses ( 6,299 ) ( 7,484 ) Total segment loss from operations $ ( 8,312 ) $ ( 6,589 ) Restructuring related charge (1) (2) ( 1,509 ) ( 40 ) Restructuring expense (3) (4) ( 6,317 ) ( 432 ) Loss from operations $ ( 16,138 ) $ ( 7,061 ) Interest expense ( 121 ) — Interest income 761 911 Other expense ( 898 ) ( 560 ) Loss before income taxes $ ( 16,396 ) $ ( 6,710 ) (1 ) During the nine months ended January 26, 2025, gross profit includes restructuring related charges totaling $ 1.5 million for losses on the disposal and valuation of inventory related to the gradual discontinuation of operations at our manufacturing facility located in Quebec, Canada. (2) During the nine months ending January 28, 2024, gross profit includes a restructuring related charge of $ 40,000 , which represents markdowns of inventory related to the discontinuation of production of cut and sewn upholstery kits at the company's facility located in Ouanaminthe, Haiti. 3) During the nine months ending January 26, 2025, restructuring expense of $ 6.3 million mostly relates to the mattress fabrics segment. The $ 6.3 million restructuring expense represents (i) $ 2.7 million for the consolidation of our mattress fabrics operations located in Quebec, Canada into our facility located in Stokesdale, North Carolina, (ii) $ 1.5 million for impairment of and accelerated depreciation related to property, plant, and equipment, (iii) $ 1.4 million for employee termination benefits, and (iv) $ 849,000 for lease termination costs, partially offset by a gain on sale and disposal of equipment totaling $( 174,000 ). See Note 10 to the consolidated financial statements for further details and description of our Fiscal 2025 Restructuring Plan. (4) Restructuring expense of $ 432,000 for the nine months ending January 28, 2024 , represents a $ 329,000 impairment charge associated with equipment and $ 103,000 for employee termination benefits related to the discontinuation of production of cut and sewn upholstery kits in Ouanaminthe, Haiti. Balance sheet information for our operating segments follows: (dollars in thousands) January 26, 2025 January 28, 2024 April 28, 2024 Segment assets: Mattress Fabrics: Accounts receivable $ 11,607 $ 11,463 $ 10,003 Inventory 31,377 27,925 27,671 Property, plant and equipment (1) 24,210 32,263 31,472 Right of use assets (2) 200 1,798 1,627 Assets held for sale (3) 2,214 — — Total mattress fabrics assets 69,608 73,449 70,773 Upholstery Fabrics: Accounts receivable 11,552 12,223 11,135 Inventory 17,222 18,952 17,172 Property, plant and equipment (4) 1,117 1,155 1,125 Right of use assets (5) 2,647 2,345 1,952 Total upholstery fabrics assets 32,538 34,675 31,384 Total segment assets 102,146 108,124 102,157 Non-segment assets: Cash and cash equivalents 5,279 12,585 10,012 Short-term investments - rabbi trust 1,753 937 903 Short-term notes receivable 526 260 264 Current income taxes receivable 1,137 476 350 Other current assets 2,619 4,237 3,371 Long-term notes receivable 1,254 1,530 1,462 Deferred income taxes 490 531 518 Property, plant and equipment (6) 612 603 585 Right of use assets (7) 3,256 2,809 2,624 Intangible assets 1,594 1,970 1,876 Long-term investments - rabbi trust 6,250 7,083 7,102 Other assets 639 853 830 Total assets $ 127,555 $ 141,998 $ 132,054 (1) The $ 24.2 million as of January 26, 2025, represents property, plant, and equipment of $ 23.0 million, $ 973,000 and $ 221,000 located in the U.S., Haiti, and Canada, respectively. The $ 32.3 million as of January 28, 2024 , represents property, plant, and equipment of $ 21.9 million, $ 9.8 million, and $ 600,000 located in the U.S., Canada, and Haiti, respectively. The $ 31.5 million as of April 28, 2024, represents property, plant, and equipment of $ 21.5 million, $ 9.4 million, and $ 555,000 located in the U.S., Canada, and Haiti, respectively. (2) The $ 200,000 as of January 26, 2025, represents a right of use asset in Haiti. The $ 1.8 million as of January 28, 2024 , represents right of use assets of $ 1.2 million and $ 604,000 located in Haiti and Canada, respectively. The $ 1.6 million as of April 28, 2024, represents right of use assets of $ 1.1 million and $ 545,000 located in Haiti and Canada, respectively. (3) The $ 2.2 million as of January 26, 2025, represents assets held for sale located in Canada. (4) The $ 1.1 million as of January 26, 2025, represents property, plant, and equipment of $ 1.0 million and $ 83,000 located in the U.S. and China, respectively. The $ 1.2 million as of January 28, 2024 , represents property, plant, and equipment of $ 1.1 million and $ 134,000 located in the U.S. and China, respectively. The $ 1.1 million as of April 28, 2024, represents property, plant, and equipment of $ 1.0 million and $ 120,000 located in the U.S. and China, respectively. (5) The $ 2.6 million as of January 26, 2025, represents right of use assets of $ 1.9 million and $ 764,000 located in China and the U.S., respectively. The $ 2.3 million as of January 28, 2024 , represents right of use assets of $ 944,000 and $ 1.4 million located in China and the U.S., respectively. The $ 2.0 million as of April 28, 2024, represents right of use assets of $ 1.3 million and $ 709,000 located in the U.S. and China, respectively. (6) The $ 612,000 , $ 603,000 , and $ 585,000 as of January 26, 2025, January 28, 2024, and April 28, 2024, respectively, represents property, plant, and equipment associated with unallocated corporate departments and corporate departments shared by our mattress fabrics and upholstery fabrics segments. Property, plant, and equipment associated with our corporate departments are located in the U.S. (7) The $ 3.3 million, $ 2.8 million, and $ 2.6 million as of January 26, 2025, January 28, 2024, and April 28, 2024, respectively, represent right of use assets located in the U.S. Information about capital expenditures and depreciation expense for our operating segments follows: Nine months ended (dollars in thousands) January 26, 2025 January 28, 2024 Capital expenditures (1): Mattress Fabrics $ 1,469 $ 2,828 Upholstery Fabrics 280 219 Unallocated Corporate 789 167 Total capital expenditures $ 2,538 $ 3,214 Depreciation expense: Mattress Fabrics (2) $ 5,166 $ 4,422 Upholstery Fabrics 464 475 Total depreciation expense $ 5,630 $ 4,897 (1) Capital expenditure amounts are stated on an accrual basis. See Consolidated Statements of Cash Flows for capital expenditure amounts on a cash basis. (2) During the nine-month period ended January 26, 2025, depreciation expense for the mattress fabrics segment included additional depreciation expense related to the shortening of useful lives of equipment associated with the gradual discontinuation of operations at our manufacturing facility located in Quebec, Canada. The amount of additional depreciation expense was $ 1.3 million and was classified as restructuring expense in the Consolidated Statements of Net Loss.

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	Jan. 26, 2025
Income Tax Disclosure [Abstract]
Summary of Differences in Income Tax Expense at Federal Income Tax Rate and Effective Income Tax Rate	The following schedule summarizes the principal differences between income tax expense at the U.S. federal income tax rate and the effective income tax rate reflected in the consolidated financial statements for the nine-month periods ended January 26, 2025, and January 28, 2024: January 26, January 28, 2025 2024 U.S. federal income tax rate 21.0 % 21.0 % U.S. valuation allowance ( 26.2 ) ( 42.0 ) Tax effects of local currency foreign exchange gain 0.7 3.8 Uncertain income tax positions 4.3 ( 0.1 ) Withholding taxes associated with foreign jurisdictions ( 1.5 ) ( 8.1 ) Captial expenditure deduction - Quebec Canada ( 1.1 ) — Foreign income tax rate differential ( 0.8 ) ( 5.2 ) Stock-based compensation ( 0.4 ) ( 2.9 ) Other 0.1 0.1 ( 3.9 )% ( 33.4 )%
Summary of Valuation Allowances Against Net Deferred Income Tax Assets	Based on our assessments as of January 26, 2025, January 28, 2024, and April 28, 2024, valuation allowances against our net deferred income tax assets pertain to the following: (dollars in thousands) January 26, 2025 January 28, 2024 April 28, 2024 U.S. federal and state net deferred income tax assets $ 23,962 $ 19,162 $ 19,674 U.S. capital loss carryforward 2,330 2,330 2,330 $ 26,292 $ 21,492 $ 22,004
Summary of Taxes Paid	The following table sets forth taxes paid by jurisdiction: Nine Months Nine Months Ended Ended January 26, January 28, (dollars in thousands) 2025 2024 United States Transition Tax Payment 665 499 China Income Taxes, Net of Refunds 1,566 1,803 Canada - Income Taxes, Net of Refunds ( 219 ) 468 $ 2,012 $ 2,770

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Jan. 26, 2025
Summary of Assumptions Used to Determine Fair Value of Performance Based Restricted Stock Units	The following table provides assumptions used to determine the fair market value of the market-based total shareholder return component using the Monte Carlo simulation model on our outstanding performance-based restricted stock units granted to senior executives on August 8, 2024, January 8, 2024, September 28, 2023, and August 10, 2022: August 8, January 8, September 28, August 10, 2024 2024 2023 2022 Closing price of our common stock $ 4.65 $ 5.61 $ 5.59 $ 5.06 Expected volatility of our common stock 35.0 % 33.5 % 37.3 % 48.2 % Expected volatility of peer companies 22.6 - 104.0 % 33.7 - 102.6 % 35.7 - 91.5 % 41.6 - 105.1 % Risk-free interest rate 3.90 % 4.3 % 4.9 % 3.13 % Dividend yield - % - % - % - % Correlation coefficient of peer companies ( 0.01 ) - 0.17 0.01 - 0.21 0.01 - 0.21 0.05 - 0.23
Executive officers and key employees [Member]
Summary of Grants of Performance Based Restricted Stock Units	The following table summarizes information related to our grants of performance-based restricted stock units associated with senior executives that were unvested as of January 26, 2025: (2) (3) Performance-Based Restricted Stock Restricted Stock Units Expected Date of Grant Units Awarded to Vest Price Per Share Vesting Period August 8, 2024 (1) 505,003 50,500 $ 5.35 (4) 36 months January 8, 2024 (1) 24,598 4,238 $ 6.23 (5) 31 months September 28, 2023 (1) 192,771 — $ 6.43 (6) 34 months August 10, 2022 (1) 146,048 — $ 5.77 (7) 3 years (1) Performance-based restricted stock units awarded to senior executives. (2) Amounts represent the maximum number of common stock shares that could be earned if certain performance targets are met as defined in the related restricted stock unit agreements. (3) Compensation cost is based on an assessment each reporting period to determine the probability of whether or not certain performance goals will be met and how many shares are expected to be earned as of the end of the vesting period. These amounts represent the number of shares that were expected to vest as of January 26, 2025. (4) Price per share represents the fair market value per share ($ 1.15 per $1, or an increase of $ 0.70 to the closing price of our common stock on the date of grant) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($ 4.65 ) for the performance-based component of the performance-based restricted stock units granted to senior executives on August 8, 2024. (5) Price per share represents the fair market value per share ($ 1.11 per $1, or an increase of $ 0.62 to the closing price of our common stock on the date of grant) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($ 5.61 ) for the performance-based component of the performance-based restricted stock units granted to a senior executive on January 8, 2024. (6) Price per share represents the fair market value per share ($ 1.15 per $1, or an increase of $ 0.84 to the closing price of our common stock on the date of grant) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($ 5.59 ) for the performance-based component of the performance-based restricted stock units granted to senior executives on September 28, 2023. (7) Price per share represents the fair market value per share ($ 1.14 per $1, or an increase of $ 0.71 to the closing price of our common stock on the date of grant) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($ 5.06 ) for the performance-based component of the performance-based restricted stock units granted to senior executives on August 10, 2022.
Senior Executives and Management [Member] | Time-Based Restricted Stock Units [Member]
Summary of Grants of Time-Based Restricted Stock Unit Awards	The following table summarizes information related to our grants of time-based restricted stock unit awards associated with senior executives, key employees, and outside directors that were unvested as of January 26, 2025: Time-Based Restricted Stock (1) Date of Grant Units Awarded Price Per Share Vesting Period January 6, 2025 (3) 21,506 $ 5.69 3 years September 26, 2024 (2) 46,823 $ 5.98 1 year August 8, 2024 (3) 17,900 $ 4.65 36 months January 8, 2024 (3) 14,758 $ 5.61 31 months September 28, 2023 (3) 86,551 $ 5.59 34 months September 6, 2022 (3) 12,557 $ 4.58 3 years August 10, 2022 (3) 62,053 $ 5.06 35 months (1) Price per share represents closing price of our common stock on the date the respective award was granted. (2) Time-based restricted stock units awarded to outside directors. (3) Time-based restricted stock units awarded to senior executives and key employees.

Leases (Tables)

Leases (Tables)	9 Months Ended
	Jan. 26, 2025
Assets and Liabilities, Lessee [Abstract]
Summary of right of use assets and lease liabilities	The right of use assets and lease liabilities associated with our operating leases as of January 26, 2025, January 28, 2024, and April 28, 2024, are as follows: (dollars in thousands) January 26, January 28, April 28, Right of use assets $ 6,103 $ 6,952 $ 6,203 Operating lease liability - current 2,025 2,524 2,061 Operating lease liability – noncurrent 3,127 2,656 2,422
Supplemental Cash Flow Information	Supplemental Cash Flow Information Nine Months Nine Months (dollars in thousands) January 26, 2025 January 28, 2024 Operating lease liability payments $ 1,694 $ 1,992 Right of use assets exchanged for lease liabilities 2,660 978
Leases-Other Information	Other Information Maturity of our operating lease liabilities for the remainder of fiscal 2025, the subsequent next four fiscal years, and thereafter follows: (dollars in thousands) 2025 655 2026 2,217 2027 1,556 2028 388 2029 227 Thereafter 576 $ 5,619 Less: interest ( 467 ) Present value of lease liabilities $ 5,152
Summary of weighted average remaining lease term and discount rate	As of January 26, 2025, the weighted average remaining lease term and discount rate for our operating leases follows: January 26, 2025 Weighted average lease term (in years) 3.24 Weighted average discount rate 5.50 %

Allowance for Doubtful Accoun_3

Allowance for Doubtful Accounts - Summary of the Activity in the Allowance for Doubtful Accounts (Detail) - Allowance for doubtful accounts [Member] - USD ($)	9 Months Ended
	Jan. 26, 2025	Jan. 28, 2024
Valuation and Qualifying Accounts Disclosure [Line Items]
Beginning balance	$ 356,000	$ 342,000
Provision for bad debts	150,000	349,000
Write-offs, net of recoveries	1,000	(30,000)
Ending balance	$ 507,000	$ 661,000

Allowance for Doubtful Accoun_4

Allowance for Doubtful Accounts - Narrative (Detail) - USD ($)	Jan. 26, 2025	Apr. 28, 2024	Jan. 28, 2024	Apr. 30, 2023
Allowance for doubtful accounts [Member]
Valuation and Qualifying Accounts Disclosure [Line Items]
Allowance for doubtful accounts	$ 507,000	$ 356,000	$ 661,000	$ 342,000

Revenue from Contracts with C_3

Revenue from Contracts with Customers - Narrative (Detail)	9 Months Ended
	Jan. 26, 2025 USD ($) Segment	Apr. 28, 2024 USD ($)	Jan. 28, 2024 USD ($)
Contract Assets and Liabilities [Line Items]
Number of operating segments | Segment	2
Contract assets recognized | $	$ 0	$ 0	$ 0
Minimum [Member]
Contract Assets and Liabilities [Line Items]
Contract with customers credit period	15 days
Maximum [Member]
Contract Assets and Liabilities [Line Items]
Contract with customers credit period	60 days

Revenue from Contracts with C_4

Revenue from Contracts with Customers - Summary of the activity associated with deferred revenue (Detail) - USD ($) $ in Thousands	9 Months Ended
	Jan. 26, 2025		Jan. 28, 2024
Revenue from Contract with Customer [Abstract]
Beginning balance	$ 1,495	[1]	$ 1,192
Revenue recognized on contract liabilities	(3,134)		(2,893)
Payments received for services not yet rendered	2,336		3,499
Ending balance	$ 697		$ 1,798
[1] Derived from audited consolidated financial statements.

Revenue from Contracts with C_5

Revenue from Contracts with Customers - Disaggregation of Revenue (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 26, 2025	Jan. 28, 2024	Jan. 26, 2025	Jan. 28, 2024
Disaggregation of Revenue [Line Items]
Total Net Sales	$ 52,253	$ 60,418	$ 164,464	$ 175,804
Transferred at Point in Time [Member] | Product [Member]
Disaggregation of Revenue [Line Items]
Total Net Sales	48,987	58,625	155,104	168,191
Transferred over Time [Member] | Services [Member]
Disaggregation of Revenue [Line Items]
Total Net Sales	3,266	1,793	9,360	7,613
Mattress Fabrics [Member]
Disaggregation of Revenue [Line Items]
Total Net Sales	28,642	30,021	86,792	90,619
Mattress Fabrics [Member] | Transferred at Point in Time [Member] | Product [Member]
Disaggregation of Revenue [Line Items]
Total Net Sales	28,642	30,021	86,792	90,619
Upholstery Fabrics [Member]
Disaggregation of Revenue [Line Items]
Total Net Sales	23,611	30,397	77,672	85,185
Upholstery Fabrics [Member] | Transferred at Point in Time [Member] | Product [Member]
Disaggregation of Revenue [Line Items]
Total Net Sales	20,345	28,604	68,312	77,572
Upholstery Fabrics [Member] | Transferred over Time [Member] | Services [Member]
Disaggregation of Revenue [Line Items]
Total Net Sales	$ 3,266	$ 1,793	$ 9,360	$ 7,613

Inventories - Summary of Invent

Inventories - Summary of Inventories (Detail) - USD ($) $ in Thousands	Jan. 26, 2025	Apr. 28, 2024		Jan. 28, 2024
Inventory Disclosure [Abstract]
Raw materials	$ 5,502	$ 6,214		$ 8,214
Work-in-process	2,371	1,854		2,388
Finished goods	40,726	36,775		36,275
Inventories	$ 48,599	$ 44,843	[1]	$ 46,877
[1] Derived from audited consolidated financial statements.

Inventories - Narrative (Detail

Inventories - Narrative (Detail) - USD ($)	9 Months Ended
	Jan. 26, 2025	Jan. 28, 2024
Inventory [Line Items]
Non-cash inventory charges		$ 2,000,000
Mattress and Upholstery Fabrics [Member]
Inventory [Line Items]
Non-cash inventory charges	$ 1,000,000
Credit related adjustments to inventory		2,000,000
Restructuring related charge		$ 40,000

Intangible Assets - Summary of

Intangible Assets - Summary of Intangible Assets (Detail) - USD ($) $ in Thousands	Jan. 26, 2025	Apr. 28, 2024		Jan. 28, 2024	Apr. 30, 2023
Intangible Assets [Line Items]
Tradename	$ 540	$ 540		$ 540
Intangible assets	1,594	1,876	[1]	1,970
Customer Relationships [Member]
Intangible Assets [Line Items]
Finite-lived intangible assets, net	809	1,035		1,110	$ 1,335
Non-Compete Agreement [Member]
Intangible Assets [Line Items]
Finite-lived intangible assets, net	$ 245	$ 301		$ 320	$ 377
[1] Derived from audited consolidated financial statements.

Intangible Assets - Narrative (

Intangible Assets - Narrative (Detail) - USD ($)	3 Months Ended		9 Months Ended		30 Months Ended
	Jan. 26, 2025	Jan. 28, 2024	Jan. 26, 2025	Jan. 28, 2024	Jan. 26, 2025	Apr. 28, 2024		Apr. 30, 2023
Intangible Assets [Line Items]
Impairment charges of tradename			$ 0
Gross carrying amount of customer relationships	$ 3,100,000	$ 3,100,000	3,100,000	$ 3,100,000	$ 3,100,000	$ 3,100,000
Incurred operating losses	(3,887,000)	(1,740,000)	(16,138,000)	(7,061,000)
Gross carrying amount of non-compete agreement	2,000,000	2,000,000	2,000,000	2,000,000	2,000,000	2,000,000
Property, plant and equipment, net	25,939,000	34,021,000	25,939,000	34,021,000	25,939,000	33,182,000	[1]
Right of use assets	6,103,000	6,952,000	6,103,000	6,952,000	6,103,000	6,203,000	[1]
Customer Relationships [Member]
Intangible Assets [Line Items]
Finite-lived intangible assets, net	809,000	1,110,000	809,000	1,110,000	809,000	1,035,000		$ 1,335,000
Accumulated amortization	2,300,000	2,000,000	2,300,000	2,000,000	2,300,000	2,100,000
Remaining amortization expense for the fiscal year	75,000		75,000		75,000
Remaining amortization expense for the first fiscal year	301,000		301,000		301,000
Remaining amortization expense for the second fiscal year	280,000		280,000		280,000
Remaining amortization expense for the third fiscal year	51,000		51,000		51,000
Remaining amortization expense for the fourth fiscal year	51,000		51,000		51,000
Remaining amortization expense for the fiscal year thereafter	$ 51,000		$ 51,000		$ 51,000
Weighted average remaining amortization period	3 years 2 months 12 days		3 years 2 months 12 days		3 years 2 months 12 days
Customer Relationships [Member] | Minimum [Member]
Intangible Assets [Line Items]
Useful life	9 years		9 years		9 years
Customer Relationships [Member] | Maximum [Member]
Intangible Assets [Line Items]
Useful life	17 years		17 years		17 years
Non-Compete Agreement [Member]
Intangible Assets [Line Items]
Useful life	15 years		15 years		15 years
Finite-lived intangible assets, net	$ 245,000	320,000	$ 245,000	320,000	$ 245,000	301,000		$ 377,000
Accumulated amortization	1,800,000	$ 1,700,000	1,800,000	$ 1,700,000	1,800,000	$ 1,700,000
Remaining amortization expense for the fiscal year	19,000		19,000		19,000
Remaining amortization expense for the first fiscal year	76,000		76,000		76,000
Remaining amortization expense for the second fiscal year	76,000		76,000		76,000
Remaining amortization expense for the third fiscal year	$ 74,000		$ 74,000		$ 74,000
Weighted average remaining amortization period	3 years 3 months 18 days		3 years 3 months 18 days		3 years 3 months 18 days
Mattress Asset Group [Member]
Intangible Assets [Line Items]
Carrying amount of asset group, net	$ 24,900,000		$ 24,900,000		$ 24,900,000
Impairment charge			0
Mattress Asset Group [Member] | Mattress Fabrics [Member]
Intangible Assets [Line Items]
Incurred operating losses					35,300,000
Mattress Asset Group [Member] | Customer Relationships [Member] | Mattress Fabrics [Member]
Intangible Assets [Line Items]
Finite-lived intangible assets, net	268,000		268,000		268,000
Mattress Asset Group [Member] | Non-Compete Agreement [Member] | Mattress Fabrics [Member]
Intangible Assets [Line Items]
Finite-lived intangible assets, net	245,000		245,000		245,000
Mattress Asset Group [Member] | Property, Plant and Equipment [Member]
Intangible Assets [Line Items]
Property, plant and equipment, net	24,200,000		24,200,000		24,200,000
Mattress Asset Group [Member] | Right Of Use Assets [Member]
Intangible Assets [Line Items]
Right of use assets	$ 200,000		$ 200,000		$ 200,000
[1] Derived from audited consolidated financial statements.

Intangible Assets - Summary o_2

Intangible Assets - Summary of Change in Carrying Amount of Finite-Lived Intangible Assets (Detail) - USD ($) $ in Thousands	9 Months Ended
	Jan. 26, 2025	Jan. 28, 2024
Customer Relationships [Member]
Finite Lived Intangible Assets [Line Items]
Beginning balance	$ 1,035	$ 1,335
Amortization expense	(226)	(225)
Ending balance	809	1,110
Non-Compete Agreement [Member]
Finite Lived Intangible Assets [Line Items]
Beginning balance	301	377
Amortization expense	(56)	(57)
Ending balance	$ 245	$ 320

Note Receivable - Narrative (De

Note Receivable - Narrative (Detail) - USD ($)		9 Months Ended
	Aug. 02, 2024	Jan. 26, 2025	Apr. 28, 2024	Jan. 28, 2024	May 01, 2023	Jan. 29, 2023
Note Receivable [Line Items]
Fair value of note receivable		$ 1,530,000
Interest rate		6%
United States [Member]
Note Receivable [Line Items]
Note receivable		$ 1,500,000	$ 1,700,000	$ 1,800,000	$ 2,400,000
Note receivable, short-term		276,000	264,000	260,000
Note receivable, long-term		1,300,000	$ 1,500,000	1,500,000
United States [Member] | Interest Income [Member]
Note Receivable [Line Items]
Amortization of unearned interest income		74,000		$ 85,000
CUF Haiti [Member]
Note Receivable [Line Items]
Lease rent advance payment		$ 2,800,000
Lease expiration date		Dec. 31, 2029
Return possession of leased facility		$ 2,400,000
Carrying amount of note receivable						$ 2,400,000
Fair value of note receivable						$ 2,000,000
CHF Termination Agreement [Member]
Note Receivable [Line Items]
Payment from lessor for advance based on original lease agreement	$ 250,000

Note Receivable - Summary of Re

Note Receivable - Summary of Remaining Future Principal Payments (Detail) $ in Thousands	Jan. 26, 2025 USD ($)
Note Receivable [Line Items]
2025	$ 90
2026	360
2027	360
2028	360
2029	360
Thereafter	240
Undiscounted value of note receivable	1,770
Less: unearned interest income	(240)
Present value of note receivable	$ 1,530

Assets Held for Sale - Narrativ

Assets Held for Sale - Narrative (Detail) $ in Thousands	Jan. 26, 2025 USD ($)
Assets Held-for-Sale [Line Items]
Assets held for sale	$ 2,214
Mattress Fabrics [Member] | Canada [Member]
Assets Held-for-Sale [Line Items]
Assets held for sale	$ 2,200

Accrued Expenses - Summary of A

Accrued Expenses - Summary of Accrued Expenses (Detail) - USD ($) $ in Thousands	Jan. 26, 2025	Apr. 28, 2024		Jan. 28, 2024
Payables and Accruals [Abstract]
Compensation, commissions and related benefits	$ 2,318	$ 4,204		$ 3,771
Other accrued expenses	3,761	2,522		3,529
Accrued expenses	$ 6,079	$ 6,726	[1]	$ 7,300
[1] Derived from audited consolidated financial statements.

Restructuring Activities - Narr

Restructuring Activities - Narrative (Detail) $ in Millions		3 Months Ended			9 Months Ended
		Jan. 26, 2025 USD ($)	Jul. 28, 2024 USD ($)	Jan. 28, 2024 USD ($)	Jan. 26, 2025 USD ($)	Jan. 28, 2024 USD ($)	Apr. 27, 2025 USD ($)	Jan. 26, 2025 CAD ($)
2025 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost		$ 10,800,000			$ 10,800,000			$ 15.5
Restructuring expense and restructuring related (credits) charges	[1],[2]	$ 2,279,000			$ 7,812,000
2025 Restructuring Plan [Member] | Scenario Forecast [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost							$ 8,500,000
Restructuring and related cost, expected cash expenditures							5,300,000
Shanghai, China [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring expense and restructuring related (credits) charges			$ 218,000
Mattress Fabrics Segment [Member] | 2025 Restructuring Plan [Member] | Scenario Forecast [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost							8,300,000
Upholstery Fabrics Segment [Member] | 2025 Restructuring Plan [Member] | Scenario Forecast [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost							155,000
CUF Haiti [Member] | Ouanaminthe, Haiti [Member] | Exit and Disposal Activity [Member]
Restructuring Cost and Reserve [Line Items]
Cumulative restructuring and related charges				$ 1,300,000		$ 1,300,000
Restructuring expense and restructuring related (credits) charges	[3],[4]			$ (111,000)		$ 472,000
Additional Depreciation Expense for Shortened Useful Lives of Equipment [Member] | Mattress Fabrics Segment [Member] | 2025 Restructuring Plan [Member] | Scenario Forecast [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost							1,300,000
Employee Termination Benefits [Member] | Mattress Fabrics Segment [Member] | 2025 Restructuring Plan [Member] | Scenario Forecast [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost							1,400,000
Lease Termination Costs [Member] | Mattress Fabrics Segment [Member] | 2025 Restructuring Plan [Member] | Scenario Forecast [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost							849,000
Other Associated Costs [Member] | Mattress Fabrics Segment [Member] | 2025 Restructuring Plan [Member] | Scenario Forecast [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost							3,300,000
Loss on Disposal and Valuation of Inventory [Member] | Mattress Fabrics Segment [Member] | 2025 Restructuring Plan [Member] | Scenario Forecast [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost							1,500,000
Partially Offset by Net Gains on Disposal of Equipment [Member] | Mattress Fabrics Segment [Member] | 2025 Restructuring Plan [Member] | Scenario Forecast [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost							$ 42,000
[1] Of the total $ 2.3 million restructuring and restructuring related charges, $ 1.7 million and $ 624,000 were classified within restructuring expense and cost of sales, respectively, in the Consolidated Statement of Net Loss for the three-month period ending January 26, 2025. The $ 2.3 million mostly relates to the mattress fabrics segment. Of the total $ 7.8 million restructuring and restructuring related charges, $ 6.3 million and $ 1.5 million were classified within restructuring expense and cost of sales, respectively, in the Consolidated Statement of Net Loss for the nine-month period ending January 26, 2025. The $ 7.8 million mostly relates to the mattress fabrics segment. Of the total $( 111,000 ), $( 50,000 ) and $( 61,000 ) were recorded within restructuring credit and cost of sales, respectively, in the Consolidated Statement of Net Loss for the three-month period ended January 28, 2024. Of the total $ 472,000 , $ 432,000 and $ 40,000 were recorded within restructuring expense and cost of sales, respectively, in the Consolidated Statement of Net Loss for the nine-month period ended January 28, 2024 .

Restructuring Activities - Summ

Restructuring Activities - Summary of Accrued Restructuring (Detail) - USD ($)		3 Months Ended				9 Months Ended
		Jan. 26, 2025		Jan. 28, 2024	[1],[2]	Jan. 26, 2025		Jan. 28, 2024	[3],[4]
Restructuring Cost and Reserve [Line Items]
Expenses incurred		$ 1,655,000	[1],[2]	$ (50,000)		$ 6,317,000	[3],[4]	$ 432,000
Shanghai, China [Member]
Restructuring Cost and Reserve [Line Items]
Beginning balance	[5]					3,000
Expenses incurred	[6]					14,000
Payments						(17,000)
Employee Termination Benefits [Member]
Restructuring Cost and Reserve [Line Items]
Expenses incurred		176,000
2025 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Expenses incurred						4,265,000
Change in estimate adjustments						(107,000)
Payments						(3,405,000)
Foreign currency exchange remeasurement						(30,000)
Ending balance		723,000				723,000
2025 Restructuring Plan [Member] | Employee Termination Benefits [Member]
Restructuring Cost and Reserve [Line Items]
Expenses incurred						1,535,000
Change in estimate adjustments						(107,000)
Payments						(896,000)
Foreign currency exchange remeasurement						(14,000)
Ending balance		518,000				518,000
2025 Restructuring Plan [Member] | Other Associated Costs [Member]
Restructuring Cost and Reserve [Line Items]
Expenses incurred		1,512,000				2,730,000
Payments						(2,509,000)
Foreign currency exchange remeasurement						(16,000)
Ending balance		$ 205,000				$ 205,000
[1] The restructuring credit of $ 50,000 for the three months ended January 28, 2024 , represents a gain on the sale of equipment related to the discontinuation of production of cut and sewn upholstery kits in Ouanaminthe, Haiti. During the three months ended January 26, 2025, restructuring expense of $ 1.7 million mostly relates to the mattress fabrics segment. The $ 1.7 million restructuring expense represents (i) $ 1.5 million for the consolidation of our mattress fabrics operations located in Quebec, Canada into our facility located in Stokesdale, North Carolina and (ii) $ 176,000 for employee termination benefits, partially offset by (iii) a net gain of $( 33,000 ) for the impairment and sale of equipment. See Note 10 to the consolidated financial statements for further details and description of our Fiscal 2025 Restructuring Plan. Restructuring expense of $ 432,000 for the nine months ending January 28, 2024 , represents a $ 329,000 impairment charge associated with equipment and $ 103,000 for employee termination benefits related to the discontinuation of production of cut and sewn upholstery kits in Ouanaminthe, Haiti. During the nine months ending January 26, 2025, restructuring expense of $ 6.3 million mostly relates to the mattress fabrics segment. The $ 6.3 million restructuring expense represents (i) $ 2.7 million for the consolidation of our mattress fabrics operations located in Quebec, Canada into our facility located in Stokesdale, North Carolina, (ii) $ 1.5 million for impairment of and accelerated depreciation related to property, plant, and equipment, (iii) $ 1.4 million for employee termination benefits, and (iv) $ 849,000 for lease termination costs, partially offset by a gain on sale and disposal of equipment totaling $( 174,000 ). See Note 10 to the consolidated financial statements for further details and description of our Fiscal 2025 Restructuring Plan. Accrued restructuring expense of $ 3,000 was reported within accrued expenses in the Consolidated Balance Sheet for the period ended April 28, 2024. Expenses incurred represent other associated costs and were recognized in our Consolidated Statement of Net Loss for the nine-month period ended January 26, 2025.

Restructuring Activities - Su_2

Restructuring Activities - Summary of Activity in Accrued Restructuring (Parenthetical) (Detail) - Shanghai, China [Member]	Apr. 28, 2024 USD ($)
Restructuring Cost and Reserve [Line Items]
Accrued restructuring	$ 3,000	[1]
Accrued Expenses [Member]
Restructuring Cost and Reserve [Line Items]
Accrued restructuring	$ 3,000
[1] Accrued restructuring expense of $ 3,000 was reported within accrued expenses in the Consolidated Balance Sheet for the period ended April 28, 2024.

Restructuring Activities - Su_3

Restructuring Activities - Summary of Restructuring Expense and Restructuring Related Charges (Credits) (Detail) - USD ($)		3 Months Ended				9 Months Ended
		Jan. 26, 2025		Jan. 28, 2024		Jan. 26, 2025		Jan. 28, 2024
Restructuring related charge
Restructuring expense		$ 1,655,000	[1],[2]	$ (50,000)	[1],[2]	$ 6,317,000	[3],[4]	$ 432,000	[3],[4]
Gain sale of equipment						(27,000)		(284,000)
Employee Termination Benefits [Member]
Restructuring related charge
Restructuring expense		176,000
2025 Restructuring Plan [Member]
Restructuring related charge
Restructuring expense						4,265,000
Restructuring expense and restructuring related (credits) charges	[5],[6]	2,279,000				7,812,000
2025 Restructuring Plan [Member] | Additional Depreciation Expense for Shortened Useful Lives of Equipment [Member]
Restructuring related charge
Restructuring expense		0				1,339,000
2025 Restructuring Plan [Member] | Employee Termination Benefits [Member]
Restructuring related charge
Restructuring expense						1,535,000
Employee termination benefits		176,000				1,428,000
2025 Restructuring Plan [Member] | Other Associated Costs [Member]
Restructuring related charge
Restructuring expense		1,512,000				2,730,000
2025 Restructuring Plan [Member] | Loss on Disposal, Valuation and Markdowns of Inventory [Member]
Restructuring related charge
Restructuring related charge		624,000				1,509,000
2025 Restructuring Plan [Member] | Lease Termination Costs [Member]
Restructuring related charge
Restructuring expense		0				849,000
2025 Restructuring Plan [Member] | Net Gain on Disposal of Equipment [Member]
Restructuring related charge
Restructuring expense		$ (33,000)				$ (43,000)
Exit and Disposal Activity [Member] | CUF Haiti [Member] | Ouanaminthe, Haiti [Member]
Restructuring related charge
Restructuring expense				(50,000)				432,000
Restructuring expense and restructuring related (credits) charges	[7],[8]			(111,000)				472,000
Exit and Disposal Activity [Member] | Employee Termination Benefits [Member] | CUF Haiti [Member] | Ouanaminthe, Haiti [Member]
Restructuring related charge
Restructuring expense				0				103,000
Exit and Disposal Activity [Member] | Impairment Loss - Leasehold Improvements and Equipment [Member] | CUF Haiti [Member] | Ouanaminthe, Haiti [Member]
Restructuring related charge
Restructuring expense				0				329,000
Exit and Disposal Activity [Member] | (Gain) Loss on Disposal and Markdowns of Inventory [Member] | CUF Haiti [Member] | Ouanaminthe, Haiti [Member]
Restructuring related charge
Restructuring related charge				(61,000)				$ 40,000
Exit and Disposal Activity [Member] | Gains on Sale of Equipment [Member] | CUF Haiti [Member] | Ouanaminthe, Haiti [Member]
Restructuring related charge
Restructuring expense				$ (50,000)
[1] The restructuring credit of $ 50,000 for the three months ended January 28, 2024 , represents a gain on the sale of equipment related to the discontinuation of production of cut and sewn upholstery kits in Ouanaminthe, Haiti. During the three months ended January 26, 2025, restructuring expense of $ 1.7 million mostly relates to the mattress fabrics segment. The $ 1.7 million restructuring expense represents (i) $ 1.5 million for the consolidation of our mattress fabrics operations located in Quebec, Canada into our facility located in Stokesdale, North Carolina and (ii) $ 176,000 for employee termination benefits, partially offset by (iii) a net gain of $( 33,000 ) for the impairment and sale of equipment. See Note 10 to the consolidated financial statements for further details and description of our Fiscal 2025 Restructuring Plan. Restructuring expense of $ 432,000 for the nine months ending January 28, 2024 , represents a $ 329,000 impairment charge associated with equipment and $ 103,000 for employee termination benefits related to the discontinuation of production of cut and sewn upholstery kits in Ouanaminthe, Haiti. During the nine months ending January 26, 2025, restructuring expense of $ 6.3 million mostly relates to the mattress fabrics segment. The $ 6.3 million restructuring expense represents (i) $ 2.7 million for the consolidation of our mattress fabrics operations located in Quebec, Canada into our facility located in Stokesdale, North Carolina, (ii) $ 1.5 million for impairment of and accelerated depreciation related to property, plant, and equipment, (iii) $ 1.4 million for employee termination benefits, and (iv) $ 849,000 for lease termination costs, partially offset by a gain on sale and disposal of equipment totaling $( 174,000 ). See Note 10 to the consolidated financial statements for further details and description of our Fiscal 2025 Restructuring Plan. Of the total $ 2.3 million restructuring and restructuring related charges, $ 1.7 million and $ 624,000 were classified within restructuring expense and cost of sales, respectively, in the Consolidated Statement of Net Loss for the three-month period ending January 26, 2025. The $ 2.3 million mostly relates to the mattress fabrics segment. Of the total $ 7.8 million restructuring and restructuring related charges, $ 6.3 million and $ 1.5 million were classified within restructuring expense and cost of sales, respectively, in the Consolidated Statement of Net Loss for the nine-month period ending January 26, 2025. The $ 7.8 million mostly relates to the mattress fabrics segment. Of the total $( 111,000 ), $( 50,000 ) and $( 61,000 ) were recorded within restructuring credit and cost of sales, respectively, in the Consolidated Statement of Net Loss for the three-month period ended January 28, 2024. Of the total $ 472,000 , $ 432,000 and $ 40,000 were recorded within restructuring expense and cost of sales, respectively, in the Consolidated Statement of Net Loss for the nine-month period ended January 28, 2024 .

Restructuring Activities - Su_4

Restructuring Activities - Summary of Restructuring Expense and Restructuring Related Charges (credits) (Parenthetical) (Detail) - USD ($)		3 Months Ended				9 Months Ended
		Jan. 26, 2025		Jan. 28, 2024		Jan. 26, 2025		Jan. 28, 2024
Restructuring Cost and Reserve [Line Items]
Restructuring expense		$ 1,655,000	[1],[2]	$ (50,000)	[1],[2]	$ 6,317,000	[3],[4]	$ 432,000	[3],[4]
2025 Restructuring Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring expense and restructuring related (credits) charges	[5],[6]	2,279,000				7,812,000
Restructuring expense						4,265,000
2025 Restructuring Plan [Member] | Cost of Sales [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring related charge		$ 624,000				$ 1,500,000
Exit and Disposal Activity [Member] | CUF Haiti [Member] | Ouanaminthe, Haiti [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring expense and restructuring related (credits) charges	[7],[8]			(111,000)				472,000
Restructuring expense				(50,000)				432,000
Exit and Disposal Activity [Member] | CUF Haiti [Member] | Cost of Sales [Member] | Ouanaminthe, Haiti [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring related charge				$ (61,000)				$ 40,000
[1] The restructuring credit of $ 50,000 for the three months ended January 28, 2024 , represents a gain on the sale of equipment related to the discontinuation of production of cut and sewn upholstery kits in Ouanaminthe, Haiti. During the three months ended January 26, 2025, restructuring expense of $ 1.7 million mostly relates to the mattress fabrics segment. The $ 1.7 million restructuring expense represents (i) $ 1.5 million for the consolidation of our mattress fabrics operations located in Quebec, Canada into our facility located in Stokesdale, North Carolina and (ii) $ 176,000 for employee termination benefits, partially offset by (iii) a net gain of $( 33,000 ) for the impairment and sale of equipment. See Note 10 to the consolidated financial statements for further details and description of our Fiscal 2025 Restructuring Plan. Restructuring expense of $ 432,000 for the nine months ending January 28, 2024 , represents a $ 329,000 impairment charge associated with equipment and $ 103,000 for employee termination benefits related to the discontinuation of production of cut and sewn upholstery kits in Ouanaminthe, Haiti. During the nine months ending January 26, 2025, restructuring expense of $ 6.3 million mostly relates to the mattress fabrics segment. The $ 6.3 million restructuring expense represents (i) $ 2.7 million for the consolidation of our mattress fabrics operations located in Quebec, Canada into our facility located in Stokesdale, North Carolina, (ii) $ 1.5 million for impairment of and accelerated depreciation related to property, plant, and equipment, (iii) $ 1.4 million for employee termination benefits, and (iv) $ 849,000 for lease termination costs, partially offset by a gain on sale and disposal of equipment totaling $( 174,000 ). See Note 10 to the consolidated financial statements for further details and description of our Fiscal 2025 Restructuring Plan. Of the total $ 2.3 million restructuring and restructuring related charges, $ 1.7 million and $ 624,000 were classified within restructuring expense and cost of sales, respectively, in the Consolidated Statement of Net Loss for the three-month period ending January 26, 2025. The $ 2.3 million mostly relates to the mattress fabrics segment. Of the total $ 7.8 million restructuring and restructuring related charges, $ 6.3 million and $ 1.5 million were classified within restructuring expense and cost of sales, respectively, in the Consolidated Statement of Net Loss for the nine-month period ending January 26, 2025. The $ 7.8 million mostly relates to the mattress fabrics segment. Of the total $( 111,000 ), $( 50,000 ) and $( 61,000 ) were recorded within restructuring credit and cost of sales, respectively, in the Consolidated Statement of Net Loss for the three-month period ended January 28, 2024. Of the total $ 472,000 , $ 432,000 and $ 40,000 were recorded within restructuring expense and cost of sales, respectively, in the Consolidated Statement of Net Loss for the nine-month period ended January 28, 2024 .

Lines of Credit - Narrative (De

Lines of Credit - Narrative (Detail)					9 Months Ended
	Nov. 06, 2025	Jan. 26, 2025 USD ($)	Nov. 05, 2024 CNY (¥)	Mar. 20, 2024 CNY (¥)	Jan. 26, 2025 USD ($)	Jan. 28, 2024 USD ($)	Mar. 07, 2025 USD ($)	Jan. 26, 2025 CNY (¥)	Apr. 28, 2024 USD ($)
Revolving Credit Facility [Member] | United States [Member]
Line Of Credit Facility [Line Items]
Applicable interest rate at end of period		5.80%			5.80%	6.81%		5.80%	6.81%
Letters of credit, outstanding amount		$ 925,000			$ 925,000	$ 535,000			$ 535,000
Line of credit facility, available borrowing		23,200,000			23,200,000
Outstanding amount		0			0	0			$ 0
Interest paid during the year					16,000	$ 0
Revolving Credit Facility [Member] | United States [Member] | ABL Credit Agreement [Member]
Line Of Credit Facility [Line Items]
Maximum borrowing capacity		35,000,000			$ 35,000,000
Expiration date					Jan. 19, 2026
Maximum amount of letters of credit		$ 1,000,000			$ 1,000,000
Line of credit facility, accounts receivable, borrowing base percentage		85%			85%			85%
Line of credit facility, borrowing base percentage of eligible inventory value		65%			65%			65%
Line of credit facility, borrowing base percentage of net-orderly-liquidation value of eligible inventory value		85%			85%			85%
Line of credit facility, borrowing base percentage of eligible in-transit inventory value		65%			65%			65%
Line of credit facility, borrowing base percentage of net-orderly-liquidation value of eligible in-transit inventory value		85%			85%			85%
Line of credit facility, borrowing base percentage of eligible raw material inventory value		65%			65%			65%
Line of credit facility, borrowing base percentage of net-orderly-liquidation value of eligible raw material inventory value		85%			85%			85%
Line of credit facility, borrowing base eligible in-transit inventory value		$ 5,000,000			$ 5,000,000
Line of credit stated amount to determine borrowing base		$ 22,500,000			$ 22,500,000
Debt instrument, interest rate terms					The ABL Facility permits both base rate borrowings and borrowings based upon daily simple SOFR (the secured overnight financing rate administered by the Federal Reserve Bank of New York (or its successor)). Borrowings under the ABL Facility bear interest at an annual rate equal to daily simple SOFR plus 150 basis points (if the average monthly excess availability under the ABL Facility is greater than 50%) or 175 basis points (if the average monthly excess availability under the ABL Facility is less than or equal to 50%) or 50 basis points above base rate (if the average monthly excess availability under the ABL Facility is greater than 50%) or 75 basis points above base rate (if the average monthly excess availability under the ABL Facility is less than or equal to 50%), as applicable, with a fee on unutilized commitments at an annual rate of 37.5 basis points and an annual servicing fee of $12,000.
Annual servicing fee					$ 12,000
Line of credit facility, equal to eligible accounts receivable, borrowing base percent		200%			200%			200%
Threshold amount to determine excess borrowing availability		$ 35,000,000			$ 35,000,000
Number of consecutive days in which if no event of default occurs, the compliance period ends		60 days
Line of credit facility, fixed charge ratio		1.1			1.1			1.1
Line of credit facility, commitment fee percentage					37.50%
Revolving Credit Facility [Member] | United States [Member] | Letters of Credit [Member]
Line Of Credit Facility [Line Items]
Remaining letters of credit		$ 75,000			$ 75,000
Revolving Credit Facility [Member] | United States [Member] | Subsequent Event [Member]
Line Of Credit Facility [Line Items]
Outstanding amount							$ 6,000,000
Revolving Credit Facility [Member] | China [Member]
Line Of Credit Facility [Line Items]
Applicable interest rate at end of period				2.95%
Revolving Credit Facility [Member] | Minimum [Member] | United States [Member] | ABL Credit Agreement [Member]
Line Of Credit Facility [Line Items]
Line of credit facility, excess borrowing ability		7,000,000			7,000,000
Line of credit facility, covenant, excess borrowing availability		5,250,000			$ 5,250,000
Revolving Credit Facility [Member] | Minimum [Member] | United States [Member] | Base Rate [Member] | ABL Credit Agreement [Member]
Line Of Credit Facility [Line Items]
Debt instrument, basis spread on interest rate					50%
Revolving Credit Facility [Member] | Minimum [Member] | United States [Member] | Secured Overnight Financing Rate (SOFR) [Member] | ABL Credit Agreement [Member]
Line Of Credit Facility [Line Items]
Debt instrument, basis spread on interest rate					150%
Revolving Credit Facility [Member] | Maximum [Member] | United States [Member] | ABL Credit Agreement [Member]
Line Of Credit Facility [Line Items]
Line of credit facility minimum excess borrowing ability cash dominion period		7,000,000			$ 7,000,000
Line of credit facility, minimum excess borrowing ability compliance period		5,250,000			$ 5,250,000
Revolving Credit Facility [Member] | Maximum [Member] | United States [Member] | Base Rate [Member] | ABL Credit Agreement [Member]
Line Of Credit Facility [Line Items]
Debt instrument, basis spread on interest rate					75%
Revolving Credit Facility [Member] | Maximum [Member] | United States [Member] | Secured Overnight Financing Rate (SOFR) [Member] | ABL Credit Agreement [Member]
Line Of Credit Facility [Line Items]
Debt instrument, basis spread on interest rate					175%
Revolving credit agreements [Member] | China [Member]
Line Of Credit Facility [Line Items]
Maximum borrowing capacity		4,000,000		¥ 29,000,000	$ 4,000,000
Outstanding amount		4,000,000			4,000,000			¥ 29,000,000
Revolving credit agreements [Member] | China [Member] | Credit Agreement Expires March 7, 2025 [Member]
Line Of Credit Facility [Line Items]
Maximum borrowing capacity | ¥				¥ 9,600,000
Expiration date				Mar. 07, 2025
Revolving credit agreements [Member] | China [Member] | Credit Agreement Expires March 8, 2025 [Member]
Line Of Credit Facility [Line Items]
Maximum borrowing capacity | ¥				¥ 9,700,000
Expiration date				Mar. 08, 2025
Revolving credit agreements [Member] | China [Member] | Credit Agreement Expires March 9, 2025 [Member]
Line Of Credit Facility [Line Items]
Maximum borrowing capacity | ¥				¥ 9,700,000
Expiration date				Mar. 09, 2025
Revolving credit agreements [Member] | China [Member] | Base Rate [Member]
Line Of Credit Facility [Line Items]
Debt instrument, basis spread on interest rate				50%
Bank Of China [Member] | China [Member] | Credit Agreement [Member]
Line Of Credit Facility [Line Items]
Letters of credit, outstanding amount		0			0
Bank Of China [Member] | China [Member] | Letters of Credit [Member] | Credit Agreement [Member]
Line Of Credit Facility [Line Items]
Expiration date			Jul. 31, 2025
Bank Of China [Member] | Secured Line Of Credit By Trade Receivable [Member] | China [Member] | Credit Agreement [Member]
Line Of Credit Facility [Line Items]
Maximum borrowing capacity		$ 3,500,000	¥ 25,000,000		$ 3,500,000
Bank Of China [Member] | Revolving credit agreements [Member] | China [Member]
Line Of Credit Facility [Line Items]
Interest rate description				Interest charged under this agreement is based on the Loan Prime Rate ("LPR") in China minus 50 basis points at the time of borrowing, which represents 2.95%.
Bank Of China [Member] | Revolving credit agreements [Member] | China [Member] | Credit Agreement [Member]
Line Of Credit Facility [Line Items]
Applicable interest rate at end of period		2.60%			2.60%			2.60%
Interest rate description		Interest is charged under the Agreement based on the LPR in China minus 50 basis points at the time of borrowing which represents 2.60%.
Bank Of China [Member] | Revolving credit agreements [Member] | China [Member] | Credit Agreement [Member] | Base Rate [Member]
Line Of Credit Facility [Line Items]
Debt instrument, basis spread on interest rate			50%
Bank Of China [Member] | Working Capital Loan [Member] | China [Member] | Credit Agreement [Member]
Line Of Credit Facility [Line Items]
Maximum borrowing capacity		$ 1,400,000	¥ 10,000,000		$ 1,400,000
Expiration date	Nov. 06, 2025
Line of credit		$ 1,400,000			$ 1,400,000			¥ 10,000,000

Fair Value - Recurring Basis (D

Fair Value - Recurring Basis (Detail) - Fair Value, Measurements, Recurring [Member] - USD ($) $ in Thousands	Jan. 26, 2025	Apr. 28, 2024	Jan. 28, 2024
U.S. Government Money Market Fund [Member]
Assets:
Investments at fair value	$ 6,606	$ 6,910	$ 6,995
Growth Allocation Mutual Funds [Member]
Assets:
Investments at fair value	835	691	656
S&P 500 Index Fund [Member]
Assets:
Investments at fair value	275	176	156
Other [Member]
Assets:
Investments at fair value	287	228	213
Quoted prices in active markets for identical assets - Level 1 [Member] | U.S. Government Money Market Fund [Member]
Assets:
Investments at fair value	6,606	6,910	6,995
Quoted prices in active markets for identical assets - Level 1 [Member] | Growth Allocation Mutual Funds [Member]
Assets:
Investments at fair value	835	691	656
Quoted prices in active markets for identical assets - Level 1 [Member] | S&P 500 Index Fund [Member]
Assets:
Investments at fair value	275	176	156
Quoted prices in active markets for identical assets - Level 1 [Member] | Other [Member]
Assets:
Investments at fair value	$ 287	$ 228	$ 213

Fair Value - Narrative (Detail)

Fair Value - Narrative (Detail) - USD ($)	Jan. 26, 2025	Apr. 28, 2024		Jan. 28, 2024
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Investments (Rabbi Trust) - available for sale	$ 8,000,000	$ 8,000,000		$ 8,000,000
Short-term investments (Rabbi Trust) - available for sale	1,753,000	903,000	[1]	937,000
Long-term investments (Rabbi Trust) - available for sale	6,200,000	7,100,000		7,100,000
Accumulated unrealized gain (loss) on investments	$ 216,000	$ 118,000		$ 88,000
Investment, Type [Extensible Enumeration]	us-gaap:InvestmentsMember	us-gaap:InvestmentsMember		us-gaap:InvestmentsMember
[1] Derived from audited consolidated financial statements.

Net Loss Per Share - Narrative

Net Loss Per Share - Narrative (Detail) - shares	3 Months Ended		9 Months Ended
	Jan. 26, 2025	Jan. 28, 2024	Jan. 26, 2025	Jan. 28, 2024
Earnings Per Share [Abstract]
Weighted average shares used in the computation of basic, net loss per share	12,559,000	12,470,000	12,514,000	12,419,000
Weighted average shares used in the computation of diluted, net loss per share	12,559,000	12,470,000	12,514,000	12,419,000

Net Loss Per Share - Schedule o

Net Loss Per Share - Schedule of Unvested Common Stock not Included in the Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Jan. 26, 2025	Jan. 28, 2024	Jan. 26, 2025	Jan. 28, 2024
Earnings Per Share [Abstract]
Antidilutive effect from decrease in the price per share of our common stock		15		4
Antidilutive effect from net loss incurred during the fiscal quarter/year	123	81	135	126
Total unvested shares of common stock not included in computation of diluted net loss per share	123	96	135	130

Segment Information - Narrative

Segment Information - Narrative (Detail)	9 Months Ended
	Jan. 26, 2025 Segment
Segment Reporting [Abstract]
Number of operating segments	2
Description of changes in reporting intangible assets in segment assets	Intangible assets are not included in segment assets, as these assets are not used by the Chief Operating Decision Maker to evaluate the respective segment’s operating performance, allocate resources to individual segments, or determine executive compensation.

Segment Information - Statement

Segment Information - Statement of Operations for Operating Segments (Detail) - USD ($) $ in Thousands		3 Months Ended				9 Months Ended
		Jan. 26, 2025		Jan. 28, 2024		Jan. 26, 2025		Jan. 28, 2024
Segment Reporting Information [Line Items]
Net sales		$ 52,253		$ 60,418		$ 164,464		$ 175,804
Gross profit		6,347		7,703		17,414		22,737
Restructuring related (charge) credit		(624)	[1],[2]	61	[1],[2]	(1,509)	[3],[4]	(40)	[3],[4]
Selling, general, and administrative expenses		8,579		9,493		27,235		29,366
Loss from operations		(3,887)		(1,740)		(16,138)		(7,061)
Restructuring expense		(1,655)	[5],[6]	50	[5],[6]	(6,317)	[7],[8]	(432)	[7],[8]
Interest expense		(63)				(121)
Interest income		255		284		761		911
Other income (expense)		15		(705)		(898)		(560)
Loss before income taxes		(3,680)		(2,161)		(16,396)		(6,710)
Mattress Fabrics [Member]
Segment Reporting Information [Line Items]
Net sales		28,642		30,021		86,792		90,619
Upholstery Fabrics [Member]
Segment Reporting Information [Line Items]
Net sales		23,611		30,397		77,672		85,185
Operating Segments [Member]
Segment Reporting Information [Line Items]
Gross profit		6,971		7,642		18,923		22,777
Loss from operations		(1,608)		(1,851)		(8,312)		(6,589)
Operating Segments [Member] | Mattress Fabrics [Member]
Segment Reporting Information [Line Items]
Net sales		28,642		30,021		86,792		90,619
Gross profit		2,743		1,520		4,862		5,997
Selling, general, and administrative expenses		3,176		3,102		9,880		9,913
Loss from operations		(433)		(1,582)		(5,018)		(3,916)
Restructuring expense						(6,300)
Operating Segments [Member] | Upholstery Fabrics [Member]
Segment Reporting Information [Line Items]
Net sales		23,611		30,397		77,672		85,185
Gross profit		4,228		6,122		14,061		16,780
Selling, general, and administrative expenses		3,549		4,030		11,056		11,969
Loss from operations		679		2,092		3,005		4,811
Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member]
Segment Reporting Information [Line Items]
Gross profit		(624)	[1],[2]			(1,509)	[3],[4]	(40)	[3],[4]
Unallocated Corporate [Member]
Segment Reporting Information [Line Items]
Gross profit	[1],[2]			61
Selling, general, and administrative expenses		1,854		2,361		6,299		7,484
Loss from operations		$ (1,854)		$ (2,361)		$ (6,299)		$ (7,484)
[1] During the three months ended January 26, 2025, gross profit includes restructuring related charges totaling $ 624,000 for losses on the disposal and valuation of inventory related to the gradual discontinuation of operations at our manufacturing facility located in Quebec, Canada. During the three months ended January 28, 2024, gross profit includes a restructuring related credit of $ 61,000 for the gain on disposal of inventory related to the discontinuation of production of cut and sewn upholstery kits at the company's facility located in Ouanaminthe, Haiti. During the nine months ended January 26, 2025, gross profit includes restructuring related charges totaling $ 1.5 million for losses on the disposal and valuation of inventory related to the gradual discontinuation of operations at our manufacturing facility located in Quebec, Canada. During the nine months ending January 28, 2024, gross profit includes a restructuring related charge of $ 40,000 , which represents markdowns of inventory related to the discontinuation of production of cut and sewn upholstery kits at the company's facility located in Ouanaminthe, Haiti. The restructuring credit of $ 50,000 for the three months ended January 28, 2024 , represents a gain on the sale of equipment related to the discontinuation of production of cut and sewn upholstery kits in Ouanaminthe, Haiti. During the three months ended January 26, 2025, restructuring expense of $ 1.7 million mostly relates to the mattress fabrics segment. The $ 1.7 million restructuring expense represents (i) $ 1.5 million for the consolidation of our mattress fabrics operations located in Quebec, Canada into our facility located in Stokesdale, North Carolina and (ii) $ 176,000 for employee termination benefits, partially offset by (iii) a net gain of $( 33,000 ) for the impairment and sale of equipment. See Note 10 to the consolidated financial statements for further details and description of our Fiscal 2025 Restructuring Plan. Restructuring expense of $ 432,000 for the nine months ending January 28, 2024 , represents a $ 329,000 impairment charge associated with equipment and $ 103,000 for employee termination benefits related to the discontinuation of production of cut and sewn upholstery kits in Ouanaminthe, Haiti. During the nine months ending January 26, 2025, restructuring expense of $ 6.3 million mostly relates to the mattress fabrics segment. The $ 6.3 million restructuring expense represents (i) $ 2.7 million for the consolidation of our mattress fabrics operations located in Quebec, Canada into our facility located in Stokesdale, North Carolina, (ii) $ 1.5 million for impairment of and accelerated depreciation related to property, plant, and equipment, (iii) $ 1.4 million for employee termination benefits, and (iv) $ 849,000 for lease termination costs, partially offset by a gain on sale and disposal of equipment totaling $( 174,000 ). See Note 10 to the consolidated financial statements for further details and description of our Fiscal 2025 Restructuring Plan.

Segment Information - Stateme_2

Segment Information - Statement of Operations for Operating Segments (Parenthetical) (Details) - USD ($)	3 Months Ended				9 Months Ended
	Jan. 26, 2025		Jan. 28, 2024		Jan. 26, 2025		Jan. 28, 2024
Segment Reporting Information [Line Items]
Gross Profit	$ 6,347,000		$ 7,703,000		$ 17,414,000		$ 22,737,000
Restructuring expense	1,655,000	[1],[2]	(50,000)	[1],[2]	6,317,000	[3],[4]	432,000	[3],[4]
Employee Termination Benefits [Member]
Segment Reporting Information [Line Items]
Restructuring expense	176,000
Operating Segments [Member]
Segment Reporting Information [Line Items]
Gross Profit	6,971,000		7,642,000		18,923,000		22,777,000
Mattress Fabrics [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Gross Profit	2,743,000		1,520,000		4,862,000		5,997,000
Restructuring expense					6,300,000
Mattress Fabrics [Member] | Operating Segments [Member] | Employee Termination Benefits [Member]
Segment Reporting Information [Line Items]
Restructuring expense					1,400,000
Mattress Fabrics [Member] | Operating Segments [Member] | Gain Loss On Disposal Of Equipment [Member]
Segment Reporting Information [Line Items]
Restructuring expense					(174,000)
Mattress Fabrics [Member] | Operating Segments [Member] | Lease Termination Costs [Member]
Segment Reporting Information [Line Items]
Restructuring expense					849,000
Mattress Fabrics [Member] | Operating Segments [Member] | Equipment Impairment Charge [Member]
Segment Reporting Information [Line Items]
Restructuring expense	33,000
Mattress Fabrics [Member] | Operating Segments [Member] | Impairment and Accelerated Depreciation Related to Property Plant and Equipment [Member]
Segment Reporting Information [Line Items]
Restructuring expense					1,500,000
Upholstery Fabrics [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Gross Profit	4,228,000		6,122,000		14,061,000		16,780,000
Ouanaminthe, Haiti [Member] | Unallocated Corporate [Member] | Selling Manufacturing Facility [Member]
Segment Reporting Information [Line Items]
Gross Profit			61,000				40,000
Ouanaminthe, Haiti [Member] | Upholstery Fabrics [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Restructuring expense							$ 432,000
Ouanaminthe, Haiti [Member] | Upholstery Fabrics [Member] | Operating Segments [Member] | Employee Termination Benefits [Member]
Segment Reporting Information [Line Items]
Restructuring expense					103,000
Ouanaminthe, Haiti [Member] | Upholstery Fabrics [Member] | Operating Segments [Member] | Gain Loss On Disposal Of Equipment [Member]
Segment Reporting Information [Line Items]
Restructuring expense			$ (50,000)
Ouanaminthe, Haiti [Member] | Upholstery Fabrics [Member] | Operating Segments [Member] | Equipment Impairment Charge [Member]
Segment Reporting Information [Line Items]
Restructuring expense					329,000
Canada [Member] | Unallocated Corporate [Member] | Selling Manufacturing Facility [Member]
Segment Reporting Information [Line Items]
Gross Profit	624,000				1,500,000
Canada [Member] | Mattress Fabrics [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Restructuring expense	$ 1,500,000				$ 2,700,000
[1] The restructuring credit of $ 50,000 for the three months ended January 28, 2024 , represents a gain on the sale of equipment related to the discontinuation of production of cut and sewn upholstery kits in Ouanaminthe, Haiti. During the three months ended January 26, 2025, restructuring expense of $ 1.7 million mostly relates to the mattress fabrics segment. The $ 1.7 million restructuring expense represents (i) $ 1.5 million for the consolidation of our mattress fabrics operations located in Quebec, Canada into our facility located in Stokesdale, North Carolina and (ii) $ 176,000 for employee termination benefits, partially offset by (iii) a net gain of $( 33,000 ) for the impairment and sale of equipment. See Note 10 to the consolidated financial statements for further details and description of our Fiscal 2025 Restructuring Plan. Restructuring expense of $ 432,000 for the nine months ending January 28, 2024 , represents a $ 329,000 impairment charge associated with equipment and $ 103,000 for employee termination benefits related to the discontinuation of production of cut and sewn upholstery kits in Ouanaminthe, Haiti. During the nine months ending January 26, 2025, restructuring expense of $ 6.3 million mostly relates to the mattress fabrics segment. The $ 6.3 million restructuring expense represents (i) $ 2.7 million for the consolidation of our mattress fabrics operations located in Quebec, Canada into our facility located in Stokesdale, North Carolina, (ii) $ 1.5 million for impairment of and accelerated depreciation related to property, plant, and equipment, (iii) $ 1.4 million for employee termination benefits, and (iv) $ 849,000 for lease termination costs, partially offset by a gain on sale and disposal of equipment totaling $( 174,000 ). See Note 10 to the consolidated financial statements for further details and description of our Fiscal 2025 Restructuring Plan.

Segment Information - Balance S

Segment Information - Balance Sheet Information by Operating Segments (Detail) - USD ($)		Jan. 26, 2025	Apr. 28, 2024		Jan. 28, 2024
Segment Reporting Information [Line Items]
Accounts receivable		$ 23,159,000	$ 21,138,000	[1]	$ 23,686,000
Inventory		48,599,000	44,843,000	[1]	46,877,000
Cash and cash equivalents		5,279,000	10,012,000	[1]	12,585,000
Short-term investments - rabbi trust		1,753,000	903,000	[1]	937,000
Short-term notes receivable		526,000	264,000	[1]	260,000
Current income taxes receivable		1,137,000	350,000	[1]	476,000
Other current assets		2,619,000	3,371,000	[1]	4,237,000
Long-term notes receivable		1,254,000	1,462,000	[1]	1,530,000
Deferred income taxes		490,000	518,000	[1]	531,000
Property, plant and equipment		25,939,000	33,182,000	[1]	34,021,000
Right of use assets		6,103,000	6,203,000	[1]	6,952,000
Assets held for sale		2,214,000
Intangible assets		1,594,000	1,876,000	[1]	1,970,000
Long-term investments - rabbi trust		6,250,000	7,102,000	[1]	7,083,000
Other assets		639,000	830,000	[1]	853,000
Total assets		127,555,000	132,054,000	[1]	141,998,000
Operating Segments [Member]
Segment Reporting Information [Line Items]
Total assets		102,146,000	102,157,000		108,124,000
Operating Segments [Member] | Mattress Fabrics [Member]
Segment Reporting Information [Line Items]
Accounts receivable		11,607,000	10,003,000		11,463,000
Inventory		31,377,000	27,671,000		27,925,000
Property, plant and equipment	[2]	24,210,000	31,472,000		32,263,000
Right of use assets	[3]	200,000	1,627,000		1,798,000
Assets held for sale	[4]	2,214,000
Total assets		69,608,000	70,773,000		73,449,000
Operating Segments [Member] | Upholstery Fabrics [Member]
Segment Reporting Information [Line Items]
Accounts receivable		11,552,000	11,135,000		12,223,000
Inventory		17,222,000	17,172,000		18,952,000
Property, plant and equipment	[5]	1,117,000	1,125,000		1,155,000
Right of use assets	[6]	2,647,000	1,952,000		2,345,000
Total assets		32,538,000	31,384,000		34,675,000
Unallocated Corporate [Member]
Segment Reporting Information [Line Items]
Cash and cash equivalents		5,279,000	10,012,000		12,585,000
Short-term investments - rabbi trust		1,753,000	903,000		937,000
Short-term notes receivable		526,000	264,000		260,000
Current income taxes receivable		1,137,000	350,000		476,000
Other current assets		2,619,000	3,371,000		4,237,000
Long-term notes receivable		1,254,000	1,462,000		1,530,000
Deferred income taxes		490,000	518,000		531,000
Property, plant and equipment	[7]	612,000	585,000		603,000
Right of use assets	[8]	3,256,000	2,624,000		2,809,000
Intangible assets		1,594,000	1,876,000		1,970,000
Long-term investments - rabbi trust		6,250,000	7,102,000		7,083,000
Other assets		$ 639,000	$ 830,000		$ 853,000
[1] Derived from audited consolidated financial statements. The $ 24.2 million as of January 26, 2025, represents property, plant, and equipment of $ 23.0 million, $ 973,000 and $ 221,000 located in the U.S., Haiti, and Canada, respectively. The $ 32.3 million as of January 28, 2024 , represents property, plant, and equipment of $ 21.9 million, $ 9.8 million, and $ 600,000 located in the U.S., Canada, and Haiti, respectively. The $ 31.5 million as of April 28, 2024, represents property, plant, and equipment of $ 21.5 million, $ 9.4 million, and $ 555,000 located in the U.S., Canada, and Haiti, respectively. The $ 200,000 as of January 26, 2025, represents a right of use asset in Haiti. The $ 1.8 million as of January 28, 2024 , represents right of use assets of $ 1.2 million and $ 604,000 located in Haiti and Canada, respectively. The $ 1.6 million as of April 28, 2024, represents right of use assets of $ 1.1 million and $ 545,000 located in Haiti and Canada, respectively. The $ 2.2 million as of January 26, 2025, represents assets held for sale located in Canada. The $ 1.1 million as of January 26, 2025, represents property, plant, and equipment of $ 1.0 million and $ 83,000 located in the U.S. and China, respectively. The $ 1.2 million as of January 28, 2024 , represents property, plant, and equipment of $ 1.1 million and $ 134,000 located in the U.S. and China, respectively. The $ 1.1 million as of April 28, 2024, represents property, plant, and equipment of $ 1.0 million and $ 120,000 located in the U.S. and China, respectively. The $ 2.6 million as of January 26, 2025, represents right of use assets of $ 1.9 million and $ 764,000 located in China and the U.S., respectively. The $ 2.3 million as of January 28, 2024 , represents right of use assets of $ 944,000 and $ 1.4 million located in China and the U.S., respectively. The $ 2.0 million as of April 28, 2024, represents right of use assets of $ 1.3 million and $ 709,000 located in the U.S. and China, respectively. The $ 612,000 , $ 603,000 , and $ 585,000 as of January 26, 2025, January 28, 2024, and April 28, 2024, respectively, represents property, plant, and equipment associated with unallocated corporate departments and corporate departments shared by our mattress fabrics and upholstery fabrics segments. Property, plant, and equipment associated with our corporate departments are located in the U.S. The $ 3.3 million, $ 2.8 million, and $ 2.6 million as of January 26, 2025, January 28, 2024, and April 28, 2024, respectively, represent right of use assets located in the U.S.

Segment Information - Balance_2

Segment Information - Balance Sheet Information by Operating Segments (Parenthetical) (Detail) - USD ($)		Jan. 26, 2025	Apr. 28, 2024		Jan. 28, 2024
Segment Reporting Information [Line Items]
Property, plant and equipment		$ 25,939,000	$ 33,182,000	[1]	$ 34,021,000
Right of use assets		6,103,000	6,203,000	[1]	6,952,000
Assets held for sale		2,214,000
Canada [Member] | Mattress Fabrics [Member]
Segment Reporting Information [Line Items]
Assets held for sale		2,200,000
Operating Segments [Member] | Mattress Fabrics [Member]
Segment Reporting Information [Line Items]
Property, plant and equipment	[2]	24,210,000	31,472,000		32,263,000
Right of use assets	[3]	200,000	1,627,000		1,798,000
Assets held for sale	[4]	2,214,000
Operating Segments [Member] | Upholstery Fabrics [Member]
Segment Reporting Information [Line Items]
Property, plant and equipment	[5]	1,117,000	1,125,000		1,155,000
Right of use assets	[6]	2,647,000	1,952,000		2,345,000
Operating Segments [Member] | United States [Member] | Mattress Fabrics [Member]
Segment Reporting Information [Line Items]
Property, plant and equipment		23,000,000	21,500,000		21,900,000
Operating Segments [Member] | United States [Member] | Upholstery Fabrics [Member]
Segment Reporting Information [Line Items]
Property, plant and equipment		1,000,000	1,000,000		1,100,000
Right of use assets		764,000	1,300,000		1,400,000
Operating Segments [Member] | Canada [Member] | Mattress Fabrics [Member]
Segment Reporting Information [Line Items]
Property, plant and equipment		221,000	9,400,000		9,800,000
Right of use assets			545,000		604,000
Assets held for sale		2,200,000
Operating Segments [Member] | Ouanaminthe, Haiti [Member] | Mattress Fabrics [Member]
Segment Reporting Information [Line Items]
Property, plant and equipment		973,000	555,000		600,000
Right of use assets		200,000	1,100,000		1,200,000
Operating Segments [Member] | China [Member] | Upholstery Fabrics [Member]
Segment Reporting Information [Line Items]
Property, plant and equipment		83,000	120,000		134,000
Right of use assets		1,900,000	709,000		944,000
Unallocated Corporate [Member]
Segment Reporting Information [Line Items]
Property, plant and equipment	[7]	612,000	585,000		603,000
Right of use assets	[8]	3,256,000	2,624,000		2,809,000
Unallocated Corporate [Member] | United States [Member]
Segment Reporting Information [Line Items]
Property, plant and equipment		612,000	585,000		603,000
Right of use assets		$ 3,300,000	$ 2,600,000		$ 2,800,000
[1] Derived from audited consolidated financial statements. The $ 24.2 million as of January 26, 2025, represents property, plant, and equipment of $ 23.0 million, $ 973,000 and $ 221,000 located in the U.S., Haiti, and Canada, respectively. The $ 32.3 million as of January 28, 2024 , represents property, plant, and equipment of $ 21.9 million, $ 9.8 million, and $ 600,000 located in the U.S., Canada, and Haiti, respectively. The $ 31.5 million as of April 28, 2024, represents property, plant, and equipment of $ 21.5 million, $ 9.4 million, and $ 555,000 located in the U.S., Canada, and Haiti, respectively. The $ 200,000 as of January 26, 2025, represents a right of use asset in Haiti. The $ 1.8 million as of January 28, 2024 , represents right of use assets of $ 1.2 million and $ 604,000 located in Haiti and Canada, respectively. The $ 1.6 million as of April 28, 2024, represents right of use assets of $ 1.1 million and $ 545,000 located in Haiti and Canada, respectively. The $ 2.2 million as of January 26, 2025, represents assets held for sale located in Canada. The $ 1.1 million as of January 26, 2025, represents property, plant, and equipment of $ 1.0 million and $ 83,000 located in the U.S. and China, respectively. The $ 1.2 million as of January 28, 2024 , represents property, plant, and equipment of $ 1.1 million and $ 134,000 located in the U.S. and China, respectively. The $ 1.1 million as of April 28, 2024, represents property, plant, and equipment of $ 1.0 million and $ 120,000 located in the U.S. and China, respectively. The $ 2.6 million as of January 26, 2025, represents right of use assets of $ 1.9 million and $ 764,000 located in China and the U.S., respectively. The $ 2.3 million as of January 28, 2024 , represents right of use assets of $ 944,000 and $ 1.4 million located in China and the U.S., respectively. The $ 2.0 million as of April 28, 2024, represents right of use assets of $ 1.3 million and $ 709,000 located in the U.S. and China, respectively. The $ 612,000 , $ 603,000 , and $ 585,000 as of January 26, 2025, January 28, 2024, and April 28, 2024, respectively, represents property, plant, and equipment associated with unallocated corporate departments and corporate departments shared by our mattress fabrics and upholstery fabrics segments. Property, plant, and equipment associated with our corporate departments are located in the U.S. The $ 3.3 million, $ 2.8 million, and $ 2.6 million as of January 26, 2025, January 28, 2024, and April 28, 2024, respectively, represent right of use assets located in the U.S.

Segment Information - Capital E

Segment Information - Capital Expenditures and Depreciation Expense for Operating Segments (Detail) - USD ($) $ in Thousands		9 Months Ended
		Jan. 26, 2025	Jan. 28, 2024
Segment Reporting Information [Line Items]
Capital expenditures	[1]	$ 2,538	$ 3,214
Depreciation expense		5,630	4,897
Operating Segments [Member] | Mattress Fabrics [Member]
Segment Reporting Information [Line Items]
Capital expenditures	[1]	1,469	2,828
Depreciation expense	[2]	5,166	4,422
Operating Segments [Member] | Upholstery Fabrics [Member]
Segment Reporting Information [Line Items]
Capital expenditures	[1]	280	219
Depreciation expense		464	475
Unallocated Corporate [Member]
Segment Reporting Information [Line Items]
Capital expenditures	[1]	$ 789	$ 167
[1] Capital expenditure amounts are stated on an accrual basis. See Consolidated Statements of Cash Flows for capital expenditure amounts on a cash basis. During the nine-month period ended January 26, 2025, depreciation expense for the mattress fabrics segment included additional depreciation expense related to the shortening of useful lives of equipment associated with the gradual discontinuation of operations at our manufacturing facility located in Quebec, Canada. The amount of additional depreciation expense was $ 1.3 million and was classified as restructuring expense in the Consolidated Statements of Net Loss.

Segment Information - Capital_2

Segment Information - Capital Expenditures and Depreciation Expense for Operating Segments (Parenthetical) (Details) - USD ($) $ in Thousands	9 Months Ended
	Jan. 26, 2025	Jan. 28, 2024
Segment Reporting Information [Line Items]
Depreciation expense	$ 4,288	$ 4,897
Operating Segments [Member] | Mattress Fabrics [Member] | Canada [Member] | Depreciation Related To Shortening Useful Lives of Equipment [Member]
Segment Reporting Information [Line Items]
Depreciation expense	$ 1,300

Income Taxes - Effective Income

Income Taxes - Effective Income Tax Rate - Narrative (Detail) - USD ($)	3 Months Ended		9 Months Ended
	Jan. 26, 2025	Jan. 28, 2024	Jan. 26, 2025	Jan. 28, 2024
Income Taxes [Line Items]
Income taxes	$ 446,000	$ 1,027,000	$ 635,000	$ 2,244,000
Effective income tax rate			(3.90%)	(33.40%)
Pre-tax income (loss)	$ (3,680,000)	$ (2,161,000)	$ (16,396,000)	$ (6,710,000)
U.S.
Income Taxes [Line Items]
Pre-tax income (loss)			$ (16,800,000)	$ (11,300,000)

Income Taxes - Differences Betw

Income Taxes - Differences Between Income Tax Expense from Continuing Operations at Federal Income Tax Rate and Effective Income Tax Rate (Detail)	9 Months Ended
	Jan. 26, 2025	Jan. 28, 2024
Income Tax Disclosure [Abstract]
U.S. federal income tax rate	21%	21%
U.S. valuation allowance	(26.20%)	(42.00%)
Tax effects of local currency foreign exchange (losses) gains	0.70%	3.80%
Uncertain income tax positions	4.30%	(0.10%)
Withholding taxes associated with foreign jurisdictions	(1.50%)	(8.10%)
Captial expenditure deduction - Quebec Canada	(1.10%)
Foreign income tax rate differential	(0.80%)	(5.20%)
Stock-based compensation	(0.40%)	(2.90%)
Other	0.10%	0.10%
Effective income tax rate	(3.90%)	(33.40%)

Income Taxes - Summary of Valua

Income Taxes - Summary of Valuation Allowances Against Net Deferred Income Tax Assets (Detail) - USD ($) $ in Thousands	Jan. 26, 2025	Apr. 28, 2024	Jan. 28, 2024
Valuation Allowance [Line Items]
Valuation allowance	$ 26,292	$ 22,004	$ 21,492
U.S. Capital Loss Carry Forwards [Member]
Valuation Allowance [Line Items]
Valuation allowance	2,330	2,330	2,330
U.S. Federal and State [Member] | Deferred Income Tax Assets [Member]
Valuation Allowance [Line Items]
Valuation allowance	$ 23,962	$ 19,674	$ 19,162

Income Taxes - Undistributed Ea

Income Taxes - Undistributed Earnings - Narrative (Detail) - USD ($) $ in Millions	9 Months Ended
	Jan. 26, 2025	Apr. 28, 2024	Jan. 28, 2024
Income Tax Disclosure [Abstract]
Dividends received deduction percentage for earnings and profits received from foreign corporation	100%
Dividends received deduction, foreign corporation ownership percentage	10%
Deferred tax liability, undistributed earnings from foreign subsidiaries	$ 5.1	$ 4.8	$ 4.7

Income Taxes - Uncertain Income

Income Taxes - Uncertain Income Tax Positions - Narrative (Detail) - USD ($) $ in Millions	Jan. 26, 2025	Apr. 28, 2024	Jan. 28, 2024
Income Taxes [Line Items]
Unrecognized tax benefits	$ 1.4
Unrecognized tax benefit that would favorably impact effective income tax rate if recognized	1.4
Income Taxes Payable - Long-Term [Member]
Income Taxes [Line Items]
Unrecognized tax benefits	$ 1.4	$ 1.3	$ 1.2

Income Taxes - Summary of Taxes

Income Taxes - Summary of Taxes Paid (Detail) - USD ($) $ in Thousands	9 Months Ended
	Jan. 26, 2025	Jan. 28, 2024
Income Taxes [Line Items]
Total income taxes paid, net of refunds	$ 2,012	$ 2,770
Domestic Tax Jurisdiction [Member] | United States [Member]
Income Taxes [Line Items]
United States Transition Tax Payment	665	499
Foreign Tax Authority [Member] | China [Member]
Income Taxes [Line Items]
Total income taxes paid, net of refunds	1,566	1,803
Foreign Tax Authority [Member] | Canada [Member]
Income Taxes [Line Items]
Total income taxes paid, net of refunds	$ (219)	$ 468

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Detail) - USD ($)						9 Months Ended
		Jan. 26, 2025	Sep. 26, 2024	Sep. 27, 2023	Jul. 03, 2023	Jan. 26, 2025	Jan. 28, 2024	Sep. 16, 2015
Performance Based Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation award, vested						0	0
Remaining unrecognized compensation expense		$ 240,000				$ 240,000
Weighted average period over which unrecognized compensation expense is expected to be recognized		2 years 4 months 24 days
Fair value of units expected to vest		$ 291,000				291,000
Performance Based Restricted Stock Units [Member] | Selling, General and Administrative Expenses [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense						$ 49,000	$ 67,000
Time-Based Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation award, vested						103,320	151,653
Fair value						$ 581,000	$ 857,000
Price per share						$ 5.63	$ 5.65
Remaining unrecognized compensation expense		731,000				$ 731,000
Weighted average period over which unrecognized compensation expense is expected to be recognized						1 year 6 months
Fair value of units expected to vest		$ 1,400,000				$ 1,400,000
Time-Based Restricted Stock Units [Member] | Outside Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation award, granted	[1]		46,823
Price Per Share	[1],[2]		$ 5.98
Time-Based Restricted Stock Units [Member] | Selling, General and Administrative Expenses [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense						$ 473,000	$ 597,000
Common Stock Awards [Member] | Outside Directors [Member] | Immediate Vesting [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation award, granted					16,616
Price Per Share					$ 5.04
Common Stock Awards [Member] | Selling, General and Administrative Expenses [Member] | Outside Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense							$ 84,000
2015 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common stock authorized for issuance								1,200,000
Amended and Restated Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common stock authorized for issuance additional				960,000
Number of shares available for future equity based grants		451,537				451,537
[1] Time-based restricted stock units awarded to outside directors. Price per share represents closing price of our common stock on the date the respective award was granted.

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of Assumptions Used to Determine Fair Value of Performance Based Restricted Stock Units (Detail) - Performance Based Restricted Stock Units [Member] - $ / shares	Aug. 08, 2024	Jan. 08, 2024	Sep. 28, 2023	Aug. 10, 2022	Aug. 01, 2024
Executive Officer [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Risk-free interest rate	3.90%	4.30%	4.90%	3.13%
Senior Executives [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Closing price of our common stock	$ 4.65	$ 5.61	$ 5.59	$ 5.06	$ 4.65
Expected volatility of our common stock	35%	33.50%	37.30%	48.20%
Dividend yield	0%	0%	0%	0%
Senior Executives [Member] | Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected volatility of peer companies	104%	102.60%	91.50%	105.10%
Correlation coefficient of peer companies	0.17%	0.21%	0.21%	0.23%
Senior Executives [Member] | Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected volatility of peer companies	22.60%	33.70%	35.70%	41.60%
Correlation coefficient of peer companies	(0.01%)	0.01%	0.01%	0.05%

Stock-Based Compensation - Su_2

Stock-Based Compensation - Summary of Grants of Performance-Based Restricted Stock Units Associated with Senior Executives and Key Employees (Detail) - Performance Based Restricted Stock Units [Member] - Senior Executives [Member] - $ / shares		Aug. 08, 2024		Jan. 08, 2024		Sep. 28, 2023		Aug. 10, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted Stock Units Awarded	[1],[2]	505,003		24,598		192,771		146,048
Restricted Stock Units Expected to Vest	[2],[3]	50,500		4,238
Price Per Share	[2]	$ 5.35	[4]	$ 6.23	[5]	$ 6.43	[6]	$ 5.77	[7]
Vesting Period	[2]	36 months		31 months		34 months		3 years
[1] Amounts represent the maximum number of common stock shares that could be earned if certain performance targets are met as defined in the related restricted stock unit agreements. Performance-based restricted stock units awarded to senior executives. Compensation cost is based on an assessment each reporting period to determine the probability of whether or not certain performance goals will be met and how many shares are expected to be earned as of the end of the vesting period. These amounts represent the number of shares that were expected to vest as of January 26, 2025. Price per share represents the fair market value per share ($ 1.15 per $1, or an increase of $ 0.70 to the closing price of our common stock on the date of grant) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($ 4.65 ) for the performance-based component of the performance-based restricted stock units granted to senior executives on August 8, 2024. Price per share represents the fair market value per share ($ 1.11 per $1, or an increase of $ 0.62 to the closing price of our common stock on the date of grant) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($ 5.61 ) for the performance-based component of the performance-based restricted stock units granted to a senior executive on January 8, 2024. Price per share represents the fair market value per share ($ 1.15 per $1, or an increase of $ 0.84 to the closing price of our common stock on the date of grant) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($ 5.59 ) for the performance-based component of the performance-based restricted stock units granted to senior executives on September 28, 2023. Price per share represents the fair market value per share ($ 1.14 per $1, or an increase of $ 0.71 to the closing price of our common stock on the date of grant) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($ 5.06 ) for the performance-based component of the performance-based restricted stock units granted to senior executives on August 10, 2022.

Stock-Based Compensation - Su_3

Stock-Based Compensation - Summary of Grants of Performance-Based Restricted Stock Units Associated with Senior Executives and Key Employees (Parenthetical) (Detail) - Performance Based Restricted Stock Units [Member] - Senior Executives [Member] - $ / shares	Aug. 08, 2024	Aug. 01, 2024	Jan. 08, 2024	Sep. 28, 2023	Aug. 10, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value multiple to closing price per share	$ 1.15		$ 1.11	$ 1.15	$ 1.14
Fair value adjustment to closing price of common stock, per share		$ 0.7	0.62	0.84	0.71
Closing price of common stock	$ 4.65	$ 4.65	$ 5.61	$ 5.59	$ 5.06

Stock-Based Compensation - Su_4

Stock-Based Compensation - Summary of Grants of Time-Based Restricted Stock Unit Awards Associated with Senior Executives and Key Employees (Detail) - Time-Based Restricted Stock Units [Member] - $ / shares		Jan. 06, 2025	Sep. 26, 2024	Aug. 08, 2024	Jan. 08, 2024	Sep. 28, 2023	Sep. 06, 2022	Aug. 10, 2022
Senior Executives and Key Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted Stock Units Awarded	[1]	21,506		17,900	14,758	86,551	12,557	62,053
Price Per Share	[1],[2]	$ 5.69		$ 4.65	$ 5.61	$ 5.59	$ 4.58	$ 5.06
Vesting Period	[1]	3 years		36 months	31 months	34 months	3 years	35 months
Outside Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted Stock Units Awarded	[3]		46,823
Price Per Share	[2],[3]		$ 5.98
Vesting Period	[3]		1 year
[1] Time-based restricted stock units awarded to senior executives and key employees. Price per share represents closing price of our common stock on the date the respective award was granted. Time-based restricted stock units awarded to outside directors.

Leases - Narrative (Detail)

Leases - Narrative (Detail) - USD ($)	3 Months Ended		9 Months Ended
	Jan. 26, 2025	Jan. 28, 2024	Jan. 26, 2025	Jan. 28, 2024
Lessee, operating lease, option to extend			renewal options for additional periods ranging up to twelve years
Operating lease expenses	$ 683,000	$ 789,000	$ 2,100,000	$ 2,300,000
Minimum [Member]
Operating lease remaining lease terms	1 year		1 year
Maximum [Member]
Operating lease remaining lease terms	7 years		7 years

Leases - Lessee Operating Lease

Leases - Lessee Operating Lease Right of Use Assets and Liabilities (Detail) - USD ($) $ in Thousands	Jan. 26, 2025	Apr. 28, 2024	[1]	Jan. 28, 2024
Assets and Liabilities, Lessee [Abstract]
Right of use assets	$ 6,103	$ 6,203		$ 6,952
Operating lease liability - current	2,025	2,061		2,524
Operating lease liability - noncurrent	$ 3,127	$ 2,422		$ 2,656
[1] Derived from audited consolidated financial statements.

Leases - Operating Leases of Le

Leases - Operating Leases of Lessee Disclosure (Detail) - USD ($) $ in Thousands	9 Months Ended
	Jan. 26, 2025	Jan. 28, 2024
Lessee Disclosure [Abstract]
Operating lease liability payments	$ 1,694	$ 1,992
Right of use assets exchanged for lease liabilities	$ 2,660	$ 978

Leases - Lessee Operating Lea_2

Leases - Lessee Operating Lease Liability Maturity (Detail) $ in Thousands	Jan. 26, 2025 USD ($)
Lessee Disclosure [Abstract]
2025	$ 655
2026	2,217
2027	1,556
2028	388
2029	227
Thereafter	576
Total	5,619
Less: interest	(467)
Present value of lease liabilities	$ 5,152

Leases - Weighted Average Lease

Leases - Weighted Average Lease Term and Discount Rate (Detail)	Jan. 26, 2025
Lessee Disclosure [Abstract]
Weighted average lease term (in years)	3 years 2 months 26 days
Weighted average discount rate	5.50%

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Detail) - USD ($)	Jan. 26, 2025	Apr. 28, 2024	[1]	Jan. 28, 2024
Commitments and Contingencies Disclosure [Line Items]
Accounts payable for capital expenditures	$ 439,000	$ 343,000		$ 19,000
Mattress Fabrics [Member] | Capital Addition Purchase Commitments [Member]
Commitments and Contingencies Disclosure [Line Items]
Open purchase commitments for equipment	$ 600,000
[1] Derived from audited consolidated financial statements.

Statutory Reserves - Narrative

Statutory Reserves - Narrative (Detail) - Subisidiary [Member] - China [Member] $ in Millions	9 Months Ended
	Jan. 26, 2025 USD ($)
Statutory Reserves [Line Items]
Percentage of net income required to be transferred to a statutory surplus reserve fund	10%
Maximum required percentage of statutory surplus reserve fund to registered capital	50%
Percentage of statutory surplus reserve fund to registered capital	50%
Statutory surplus reserve fund balance	$ 4
Minimum threshold percentage for statutory surplus reserve fund as percentage of registered capital, below which certain capital transactions are prohibited	25%

Common Stock Repurchase Progr_2

Common Stock Repurchase Program (Detail) - Common Stock [Member] - USD ($)	9 Months Ended
	Jan. 26, 2025	Jan. 28, 2024	Mar. 31, 2020
Stockholders Equity Note [Line Items]
Common stock repurchased	0	0
Remaining authorized repurchase amount	$ 3,200,000
Stock Repurchase Program March 2020 [Member]
Stockholders Equity Note [Line Items]
Authorization amount for repurchase of common stock			$ 5,000,000